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ABSTRACT 
 
“Investigating the functionality of the transmembranes in 
GusB by fusing it with LacY using the Polymerase Chain 
Reaction. “ 
Glucuronides are produced during the detoxification pathway and removed 
via the uric pathway. The Escherichia coli living within the gut acquire these 
glucuronides for their survival by utilising the glucuronide transporter (GusB). 
GusB is encoded by the gusB gene which is located within the gus operon 
along with two other structural genes. However, the substrate binding sites of 
GusB are not currently known and therefore this research project was 
focused on fusing GusB with a different well-studied secondary transporter 
known as lactose ‘permease’ (LacY). LacY is a protein which facilitates the 
movement of lactose molecules across a membrane against the 
concentration gradient. This protein is been thoroughly studied and its 
substrate binding sites are known as well as which transmembranes they are 
located in. Hence, LacY’s structure was used for comparison with GusB as 
they share structural similarity i.e. 12 transmembranes. For this project, the 
first 6 membranes of LacY was fused with the last 6 transmembranes of 
GusB by undergoing fusion polymerase chain reaction (PCR). The PCR 
method required two steps in which fragments were fused together through 
overlap extension. Initially, the fusion was successful until a primer design 
error became evident during restriction digest. This resulted in the primers 
being redesigned and the PCR was repeated. However, obtaining the fusion 
since the correction proved difficult and required numerous troubleshoots in 
which various factors such as MgCl2 concentration, DNA concentration, 
temperature and extension time was altered. Due to this difficulty, the project 
did not progress further than PCR but has provided useful information for 
future troubleshooting and potential determination of the substrate binding 
sites. 
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Chapter 1. INTRODUCTION 
A wide range of mammal gastrointestinal tracts, including humans, contains a 
variety of enterobacteria such as Escherichia coli (E. coli) (Beaud et al. 2005; 
Martinez-Medina et al. 2009). In the gastrointestinal tract, carbon sources 
such as glucose for metabolism are not readily available; hence, resulting in 
harsh conditions in which the E. coli have to survive (Wallace et al. 2010). As 
a result, E. coli have adapted to become scavengers to increase their 
chances of survival and capabilities to thrive in such difficult conditions (Liang 
et al. 2005). They do this by utilising biological transporters to acquire and 
metabolise the energy source. 
1.1. Biological Transporters  
Biological transporters are fundamental components within ion homeostasis 
as they are responsible for controlling the movement of ions and molecules 
across cell membranes. Cell membranes are composed of a semi permeable 
phospholipid bilayer which surrounds the cytoplasm (Cullis and De Kruijff 
1979; Kučerka et al. 2011). This semi permeable membrane controls the 
movement of particular ions and molecules in and out of the cell. This 
movement is achieved by the transporters as they act as ‘gate keepers’ in 
areas of the membrane and control the movement of certain substances 
(Dubyak 2004). The transporters regulate homeostasis in two main ways: 
1. Through passive diffusion across the membrane via a concentration 
gradient  
2. Via active transport. 
Facilitative transporters (also known as uniporters), are responsible for using 
passive diffusion as a mechanism for transport. In contrast to passive 
diffusion, active transport requires energy to control cellular movements as it 
goes against the concentration gradient. There are two forms of active 
transport; primary and secondary transport which is utilised by a group of 
transporters; primary and secondary transporters respectively.   
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1.1.1. Primary transporters 
Primary transporters requires energy to transport molecules against the 
concentration gradient. ATPases and ATP- binding cassette (ABC) 
transporters are examples of primary transporters that utilise ATP hydrolysis 
as their energy source (Hediger et al. 2004). ATPases are a family of 
membrane-bound proteins found in eukaryotes and prokaryotes and are 
responsible for harnessing the energy generated from the hydrolysis of ATP 
to control movements of substrates across the membrane (Pedersen and 
Amzel 1993; Finbow and Harrison 1997; Perzov et al. 2001). The ATPase 
group is comprised of multiple classes of enzymes which vary due to their 
function. These classes are P-Type, F-Type, V- type and A-type (Hilario and 
Gogarten 1993; Pedersen 2007). The other well studied primary transporter 
groups are the ABC transporters. 
ABC transporters control the movement of ions across the cytoplasmic 
membrane against the concentration gradient by hydrolysing ATP to release 
energy for active transport (Higgins 1992; Linton et al. 1998; Law et al. 2008; 
Vasiliou et al. 2009). The ABC transporters can transport a variety of 
substrates and are separated into two categories; exporters and importers. 
The importers are categorised into a further three types: Type I, Type II and 
energy coupling factor (ECF) transporters. ABC importers are only present in 
prokaryotes, whereas ABC exporters are present in both prokaryotes and 
eukaryotes (Locher 2009; Ter Beek et al. 2014; Locher 2016). Despite 
primary transporters being well studied, their mechanisms and structure is 
different to the secondary transporter family, which is the focus for this 
project.  
1.1.2. Secondary transporters 
Contrarily, cotransporters (also known as secondary transporters), do not 
require ATP directly to control movements of molecules. Instead, they utilise 
the electrochemical gradient generated by active transport as the energy 
source. In addition to this, they couple with ions, for example H+ ions, to move 
molecules against their gradients. Additionally, there are two subgroups to 
divide secondary transporters: antiporters and symporters. Antiporters 
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transport the molecules in opposite directions and symporters transport 
molecules or ions alongside an ion in the same direction.  
An example of a symporter is the sodium glucose linked cotransporter 
(SGLT). These transporters are mainly located in the kidneys and intestines 
(Crane 1965; Wright et al. 2011; Harada and Inagaki 2012), and play a 
fundamental role in the uptake of glucose from renal excretion and glucose 
homeostasis. In humans, the normal blood glucose concentration is 5.5 
mmol/ litre. When these levels start to decline, the SGLT’s continuously 
uptake glucose until levels reach the norm. Likewise, if the levels were higher 
than the normal, the SGLT’s would be inhibited to up taking glucose, thus 
maintaining the homeostasis (Poudel 2013; Poulsen et al. 2015). This 
cotransporter was first discovered by Crane (1965) when investigating 
glucose absorption. It was established that the sodium molecules require an 
electrochemical gradient to move down for the SGLT to uptake the glucose 
from the kidneys and intestines, and that in fact this electrochemical gradient 
is maintained by the sodium potassium pump (Lever 1992; Baud et al. 2016).  
On the other hand, cation-proton antiporter (CPA) family members such as 
Na+/H+ antiporters are found prevalently. They play an important role in the 
regulation pH and ion homeostasis (Padan 2014; Paulino et al. 2014). Initially, 
their activity was discovered in bacterial cells (West and Mitchell 1974) and 
has since been identified in other organisms and more widely understood. 
One of the most well studied secondary transporters is the lactose 
‘permease’, also known as LacY. This transporter is a symporter responsible 
for transporting a lactose molecule and proton across the membrane. 
Numerous studies have shown that this protein structure is composed of 12 
transmembranes helices (Abramson et al. 2003; Law et al. 2008). LacY 
shares this structural similarity with other transporters and they have been 
categorised together to form a family known as the major facilitator 
superfamily (MFS). 
1.2. Major Facilitator Superfamily (MFS)  
The major facilitator superfamily (MFS) is one of the largest families 
composed of various secondary membrane transporters which can be found 
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ubiquitously (Pao et al. 1998; Yan 2015). Each transporter is involved in a 
critical physiological process where it carries nutrients such as lipids, amino 
acids, substrates or ions across membranes by secondary transporter 
mechanisms (Saier et al. 1999; Yan 2013). Over time, the number of families 
belonging to the MFS has increased. There are over 70 proteins considered 
to be part of the MFS; each with a characterised role (Reddy et al. 2012; 
Quistgaard et al. 2016). In addition to transportation, various MFS members 
have vital roles in the signal pathway, metabolism, detoxification and 
excretion (Pao et al. 1998; Dassler et al. 2000; Peng et al. 2011; Augustin 
2010; Chen et al. 2016). Furthermore, bioinformatics and biological 
investigations revealed that MFS proteins tend to have similar structures in 
terms of being composed of 12 transmembrane helices (TM) that are 
separated into two bundles comprised of 6 TM’s each. TM 1-6 forms the N- 
domain and TM 7-12 forms the C- domain of the protein (Law et al.2008; 
Reddy et al. 2012; Bazzone et al. 2016). This knowledge has since been 
used to distinguish the structure of unknown proteins and classifying them. 
Many of the MFS proteins genes, especially in prokaryotes can be found in 
clusters known as operons. They tend to have a promoter and repressor 
protein which controls the transcription and is influenced by the availability of 
the carbon source (Crasnier 1996; Beisel and Storz 2011). However, a 
phenomenon known as catabolite repression has been shown to positively 
regulate transcription (Wanner et al. 1978; Wong et al. 1997). A catabolite 
activator protein (CAP) binding site tends to be located before the promoter 
site. CAP is a protein which assists the RNA polymerase to enhance 
transcription and is regulated by a molecule known as cyclic adenosine 
monophosphate (cAMP). This molecule’s concentration is increased when the 
carbon source levels are low, thus activating CAP and enabling transcription. 
When carbon source levels are high, cAMP levels are reduced, hence, CAP 
is inactivated (Crasnier 1996). This repression is utilised as a form of control 
by E. coli in which it encourages usage of alternative carbon sources and has 
assisted with their survival in environments where glucose is not readily 
available (Brückner and Titgemeyer 2002; Kremling et al. 2015). This 
phenomenon been extensively studied in the lac operon located in E. coli.  
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1.3. The Lac operon of E. coli  
The lac operon has been extensively studied and is one of the most 
understood operon systems and it demonstrates the typical operon structure. 
The lac operon is polycistronic as it is controlled by one promoter. In addition 
to this, there is an operator with 3 operator sites, the lacI gene which encodes 
for a repressor protein and 3 structural genes; lacZ; lacY and lacA (Jacob and 
Monod 1961; Oehler et al. 1990). For this operon to transcribe, the 
omnipresence of galactosides such as lactose are required within the 
environment. This is due to the crucial function the lactose fulfils in binding to 
the repressor protein. This prevents the repressor protein from binding to the 
operator which would otherwise inhibit gene expression (Garner and Revzin 
1981; Oehler et al. 1990; Lewis 2013). A potential consequence of lactose 
scarcity in the environment would be the repression of the operator by the 
repressor protein lacI. This repression results in an operon that would not be 
expressed, hence, transcription would be inhibited (Gilbert and Müller-Hill 
1967). This results in a negatively regulated lac operon as it is not 
consistently expressed.  
1.4. The lactose operon repressor in E. coli  
The lacI repressor was first isolated when experiments involving radioactive 
isopropyl-thio-galactoside (IPTG) were conducted to test the role of this 
protein. Gilbert and Müller-Hill’s (1966; 1967) findings demonstrated that in 
lactose depleted environments, transcription was inhibited due to the binding 
occurring between the protein and the operator. However, when IPTG (an 
allolactose imitator) was added to the reaction, the DNA was released, and 
transcription occurred due to the affinity for the operator being reduced and 
the repressor being induced (Hansen et al. 1998; Law et al. 2002; Fernández-
Castané et al. 2012). This was detected and isolated using equilibrium 
dialysis. This transcription factor has since been extensively researched and 
has been used as a model for protein-DNA interactions (Stetz et al. 2016) and 
in the analysis of mutagenic specificity (Coulondre et al. 1978; Schaaper et 
al.1986; You et al. 1999). Following the lacI gene is the gene for the first 
structural gene in this operon, lacZ.  
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1.5. β-galactosidase in E. coli  
The lacZ gene encodes for β-galactosidase which is responsible for cleaving 
lactose and allolactose to monosaccharides (Broome et al. 2010). Furthermore, 
this enzyme can catalyse the transgalactosylation of lactose to allolactose 
which is the product that can repress the lacZ gene and in turn regulate the 
production of β-galactosidase (Huber et al. 1976; Juers et al. 2012). In addition 
to this, β-galactosidase has been commonly used as a reporter gene or as a 
marker in plasmid recombination. This is due to a scientific phenomenon known 
as α- complementation (Ullmann et al. 1967; Langley et al. 1975). β-
galactosidase is a tetramer composed of four identical monomers which are 
comprised of two segments; lacZ-alpha and lacZ-omega. After their 
investigations, it was established that neither lacZ-alpha nor lacZ-omega would 
function unless both parts were present. This was first demonstrated when an 
inactive mutant β-galactosidase with a deleted sequence was able to function 
(Ullman 1992). This was due to the α-monomer fragments of the protein having 
the exact sequence but complete, thus overriding the deleted fragment and 
restoring the function of the mutant. The following structural gene in the operon 
is the lacY gene which has been extensively studied. 
1.6. Lactose ‘permease’ transporter in E. coli  
One of the members of the MFS which has been extensively studied is E. coli 
lactose ‘permease’ (LacY). LacY is encoded by the lacY gene and 
downstream of the lacZ gene. It is responsible for the uptake of galactosides 
such as lactose via active transport and transporting it across the membrane. 
LacY engages in active transport as a symporter; moving a lactose molecule 
and proton in the same direction across the membrane into the cell against 
the concentration gradient by utilising the energy created during downhill H+ 
translocation (Foster et al. 1983; Venkatesan and Kaback 1998; Kaback 
2015). LacY is 417 amino acids long and its structure has been showed to 
comprise of 12 transmembrane helices with an amino and carboxyl terminal 
which are both located in the cytoplasmic side of the membrane (see figure 1-
1). 
    18 
 
In 2003, Abramson et al. investigated the crystal structure of this protein by 
focusing on a mutant of LacY known as C154G. X-ray crystallography at an 
approximate resolution of 3.6 Å were used to obtain the crystallisation of the 
mutant’s conformation. The X-rays crystallography revealed that in fact 
C154G has 12 transmembrane helices which are separated into two 6 helix 
bundles sharing pseudo symmetry. The first 6 transmembrane bundle forms 
the N domain and the last 6 forms the C domain. The 2 domains are linked by 
a salt bridge. In between these two bundles is a hydrophilic cavity facing the 
cytoplasmic side whilst the remained periplasmic side is tightly closed. Bound 
to this cavity is a lactose homolog known as beta-D-galactopyranosyl-1-thio-
beta-D-galactopyranoside (TDG). This led to the understanding of the inward- 
facing conformation of this mutant as it was restricted to this specific 
conformation. It also became apparent that for conformational change to 
occur, a substrate such as galactoside has to bind to the binding site in the 
cavity to encourage the opening on the periplasmic side. Similar findings were 
found when the structure of a wild-type lactose permease from E. coli 
underwent an X-ray crystallography with a resolution of 3.6 ångströms (Å) 
(Guan et al. 2007). This mechanism has since become known as the 
alternating-access model (Smirnova et al 2011; Kumar et al. 2013).  Despite 
experiments such as site directed alkylation, cysteine residue replacements, 
and the alternating-access model suggesting an outward-facing conformation, 
there has been little success with obtaining the crystallisation of this 
conformation using X-ray. Nonetheless, these revelations have provided other 
important information regarding the residues required for proton translocation 
and potential sugar binding sites.  
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1.6.1. Lactose ‘permease’ proton translocation sites 
During the alternating-access mechanism, β-galactoside is coupled with a H+ 
ion and is symported during the conformation change from inward facing to 
outward facing. The proton translocation binding sites have been widely 
studied. One of the experiments used to locate the possible residues was 
cysteine-scanning mutagenesis (Frillingos et al. 1998). During this procedure, 
all of the amino acids were changed to cysteine, each mutant was then 
expressed and functionality was tested. Only 18 mutants were unable to 
catalyse lactose, however based on their properties, only 6 mutants were 
found to be completely ‘irreplaceable’. They are predominantly found in the C-
domain, specifically E126, R144, E269, R302, H322 and E325 (see figure 1-
2). As this mechanism was being understood, previously suggested proton 
translocation residues were confirmed to be correct (Abramson et al. 2003; 
Guan and Kaback 2006). Further studies revealed that the deprotonation of 
E325 may be responsible with the inward to outward facing conformational 
change. Andersson et al. (2012) used molecular dynamics to compare the 
effect of protonated and deprotonated E325 residues on the confirmation of 
Figure 1-1. Model of Lactose ‘permease’.  Model illustrating the N- and C- domain 
which are coloured blue and red respectively. Green and orange coloured residues are 
the substrate binding and proton translocation sites respectively. The TDG is 
symbolised by the two black circles (Abramson et al. 2003). 
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LacY in a sugar substrate absent environment. Results demonstrated 
changes to the salt bridges formed between various residues as well as 
possible structural change. In addition to this, it became apparent that E269 
may be involved with proton translocation and substrate binding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
1.6.2. Lactose ‘permease’ substrate binding sites 
Numerous studies suggest that the majority of substrate binding residues are 
located within the N-domain. Some of these residues include E126, R144, 
W151 and E269 (Guan et al. 2007). Initially, the protein is in outward- facing 
conformation and the proton is attracted to the negatively charged amino 
acid, E269.This triggers the substrate to bind to a residue in the N-domain 
before a salt bridge is formed between R144 and E269. This salt bridge 
formation is then believed to cause the conformation change to inward-facing 
Figure 1-2. Results from cysteine- scanning mutagenesis on Lactose Permease. 
These results display the lactose transport expression within each mutant, which 
transmembrane they are located in and their transportation rate. The circled results 
indicate the possible proton translocation sites due to inactive mutants (amended from 
Frillingos et al. 1998 p. 1284). 
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and releasing the substrate and H+ (Abramson et al. 2003; Mirza et al. 2006; 
Smirnova et al. 2009). Therefore, E269 may be responsible for both the 
binding site and proton translocation.  
By understanding the crystallisation of LacY as well as the proton 
translocation and substrate binding sites, scientists started investigating the 
binding loop and salt bridges between the N-domain and C-domain 6 TM 
bundles. Experiments focused on changing residues within the loop/ salt 
bridge participants to alter the overall charge revealed that in fact, either 
monomer (6 TM bundle) is still expressed and functions (Sahin-Toth et al. 
1992; Guan et al. 2001; Abramson et al. 2003). This knowledge has 
modified the current understanding on MFS proteins as they theoretically 
share similar structures. However, this has proved difficult to test with other 
transporters as they are not as widely understood as LacY. Conversely, the 
lacA gene which is downstream of lacY is not fully understood.  
1.7. Thiogalactoside transacetylase in E. coli  
LacA is the final structural gene located within the lac operon, after the lacY 
gene. It encodes for an enzyme known as thiogalactoside transacetylase, also 
known as Galactoside acetyltransferase or LacA. It is approximately 202 
amino acids in length and thought to be a trimer (Fowler et al. 1985; Lewendon 
et al. 1995). LacA is believed to be involved in the cellular detoxification 
process but scientists have yet to completely confirm this (Kenneth and Lin 
1976; Roderick 2005 p. 568). LacA catalyses the transfer of an acetyl group 
from acetyl-CoA to the 6-hydroxyl position on a range of substrates such as 
glucosides and galactosides (Zabin et al. 1959; Wang et al. 2002). Despite the 
function of LacA not being completely understood, the lac operon is a widely 
understood system as similar theories have been applied to other transporters 
in the MFS. 
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1.8. Xylose- H+ transporter  
LacY is not the only MFS protein to have its inward facing- form crystallised, 
another secondary transporter also located in E. coli has had its structure 
crystallised. The xylose- H+ symporter, also known as XylE has been widely 
studied. This transporter is coded by the xylE gene which is located in an 
operon, downstream of xylA and xylB which encodes for xylose isomerase 
and xylulokinase respectively (Song and Park 1997). Like other members of 
the MFS including LacY, this protein is comprised of 12 transmembrane 
helices with a N- and C- domain based on the cytoplasmic side as shown in 
figure 1-3. (Davis and Henderson 1987; Henderson and Baldwin 2012). 
Unlike LacY, this protein has been crystallised in inward- facing conformation 
as well as outward-facing conformation at 2.6 – 2.9 Å resolution (Yan 2013; 
Henderson and Baldwin 2013). Furthermore, the proton translocation sites 
are located within the first 6 transmembranes and the substrate binding sites 
are within the last 6 transmembranes, yet XylE still utilises the alternating-
access mechanism (Sun et al. 2012; Henderson and Baldwin 2013). Since 
this discovery, it has resulted in further investigation into MFS members’ 
transmembrane function as it demonstrates that despite sharing some 
structural similarities, the functions of each transmembrane can vary.  
 
 
Figure 1-3. A model of the Xylose transporter XylE. A model illustrating the 12 
transmembranes of XylE (Davis and Henderson 1987).  
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1.9. Gus Operon in E. coli  
The lac and xylose operon are not the only operons found in E. coli which 
requires suitable environmental conditions to operate. The gus operon 
requires the presence of glucuronides in order to function. In similar fashion to 
the lac operon, the gus operon is controlled by a repressor, gusR, which is 
located upstream of 3 structural genes; gusA, gusB and gusC (Wilson et al. 
1992). The first structural gene, gusA encodes for β-D-glucuronidase which is 
responsible for hydrolysing glucuronides into aglycones and glucuronic acid. 
Downstream of this gene is gusB which codes for the glucuronide transporter 
(GusB) which transports the glucuronides. The final gene in this operon, 
gusC, encodes for an outer membrane associated protein which increases 
the activity of GusB (Liang et al. 2005). β-D-glucuronidase is currently the 
most extensively researched structural gene from the gus operon and has a 
variety of uses. 
1.10. β-D-glucuronidase in E. coli 
β-D-glucuronidase, also known as GusA, is a hydrolase known to be found in 
prokaryotes and eukaryotes.  In E. coli, this protein is responsible for the 
cleaving of glucuronides produced during glucuronidation into aglycones and 
glucuronic acid. Gus A is composed of 603 amino acids and its transcription is 
regulated by repressors; uidR (gusR) and uxuR. These repressors were 
confirmed when investigations by Novel and Novel (1976) revealed inhibition 
to the transcription of GusA when bound to the operon (Blanco et al. 1985). 
This also revealed the negative regulation of GusA as the repressors would 
only bind to the operon when there is a lack of glucuronide, similar to the 
mechanism of lacI. 
E. coli, found in the gastrointestinal tract, utilise GusA in order to survive. As 
soon as an assortment of glucuronides is readily available in the environment, 
GusA hydrolyses the glucuronides into the aglycones and glucuronic acid 
components. When compounds are conjugated with glucuronic acid to form 
glucuronides during glucuronidation, their water solubility is increased and 
their ability to be absorbed into the bloodstream is reduced (Lee 1995; 
Prijovich et al. 2002; Kaushik et al. 2006). However, as GusA hydrolyses the 
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glucuronides, it separates the glucuronide into the two components. The 
glucuronic acid is metabolised by the bacteria whereas the aglycone moiety 
undergoes a phenomenon known as enterohepatic circulation (Wilson et al. 
1992; Roberts et al. 2002; Gloux et al. 2011). This process involves the 
recycling of moieties entering the gastrointestinal tract. As the glucuronides 
are hydrolysed in the intestines, some of the aglycones moieties formed are 
absorbed by enterocytes located in the intestinal wall and released into the 
bloodstream. These moieties are then transported to the liver where they are 
reabsorbed by hepatocytes to undergo glucuronidation again. On the other 
hand, the remaining aglycones located in the intestines that were not 
absorbed continue to pass through the system to be excreted via urine or 
faeces.   
GusA has been widely used as a reporter gene in plants (Jefferson et al. 
1986). Similar to the theory behind blue/ white staining, GusA is used in 
transgenic plants which contain substrates known to be cleaved by this 
enzyme. One such substrate that has been used frequently is chromogenic 5-
bromo-4-chloro-3-indoyl glucuronide (X-Gluc) (Jefferson et al. 1987; 
Platteeuw et al. 1994; Wilson et al. 1995; Yamaguchi et al. 2001; Chen et al. 
2007; Liu et al. 2013). Scientists have been able to identify the expressed 
regions as they would appear blue in colour if this enzyme is present. The 
application of this knowledge has led to the detection of various gene 
expressions and is still a commonly used method. 
1.11. Glucuronide transporter in E. coli 
Unlike the LacY transporter which has been extensively studied, the 
glucuronide transporter (GusB), found in E. coli, is not as understood. GusB is 
a key transporter involved in the survival of E. coli in the human intestinal 
tract. In 2005, Liang et al. determined the biological function and 
characteristics of this transporter as well as parts of its structure. It is 
predicted to have 12 transmembranes α-helices as well as an N- and C- 
terminal in the cytoplasmic side, similar to other MFS members. This protein 
is thought to be 457 amino acids long and is known to act as a symporter by 
coupling up with H+ ions to transport glucuronides across the membrane 
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(Liang 1992; Liang et al 2005). It does this by creating an electrochemical 
gradient and uses the proton motive force to drive the molecule into the cell.  
As a transporter, GusB recognises a wide range of glucuronides formed 
during detoxification, despite structural differences in the aglycone part of the 
molecule. However, the function of the transmembrane helices for this protein 
is unknown and therefore the substrate binding sites locations are unknown.  
Investigations are being carried out in attempt to locate these sites by using 
knowledge from other transporters such as LacY and XylE. Moreover, studies 
are being carried out in attempt to reveal the 3-dimensional structure of GusB. 
 
 
 
 
 
 
 
 
 
 
 
 
1.12. Synthesis of glucuronides  
Glucuronides are carbohydrate compounds formed during a detoxification 
pathway known as glucuronidation. The glucuronide is composed of two 
parts; glycone and aglycone. Before glucuronides are formed,uridine 5′-
diphosphate-glucuronic acid (UDP-GlcA) needs to be omnipresent as it forms 
the glycone component. UDP-GlcA is an active sugar substrate primarily 
found in hepatic tissue and is synthesized in a two-step reaction via the uronic 
Figure 1-4. A model of the glucuronide transporter GusB. A model 
illustrating the 12 transmembranes of GusB and its amino acid residues 
(Liang 1992) 
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acid. During its synthesis, glucose-6-phosphate undergoes isomeration to 
form glucose-1-phosphate (G1P). This reaction is catalysed by 
phosphoglucomutase which transfers the phosphate group from the 6 to 1 
position. G6P then reacts with uridine triphosphate (UTP) to form uridine 
diphosphate glucose (UDPGlc). This is catalysed by the enzyme uridine 
diphosphate glucose pyrophosphorylase (Turnquist et al. 1974). UDPGlc is 
then oxidised by UGDH (UDP-α-D-glucose 6-dehydrogenase) to yield UDP-
GlcA (Bar-Peled et al. 2004). This compound is then used in biosynthesizing 
of glucuronides in the process known as glucuronidation.  
1.13. Glucuronidation 
Glucuronidation is phase II of the detoxification pathway that occurs in 
mammals, predominantly in the liver. During this pathway, enzymes known as 
UDP- glucuronyltransferase (UGT) catalyse the conjugation of UDP-GlcA with 
endogenous/xenobiotics such as paracetamol, or endogenous compounds 
such as bilirubin to form the glucuronide (Burchell and Coughtrie 1989; 
Margaillan et al. 2015). UDP- GlcA does this by acting as a glucuronosyl 
donor towards a wide range of aglycones with various nucleophilic functional 
groups (Dutton 1956). Before glucuronidation, the aglycones tend to have 
higher polarity and are more active as they can penetrate cell membranes. 
Glucuronidation detoxifies these aglycones by altering their biological 
structure to form a negatively charged glucuronide. Due to the negative 
charge, the glucuronide cannot penetrate cell membranes and relies on 
transporters to transport them across the membrane (Yang et al. 2017). In 
addition to this, the glucuronide tends to have a lower half-life than the parent 
compounds. Moreover, this results in the reduction of the toxicity of these 
compounds and increases their water solubility due to the increase in 
hydrophilic properties, thus allow easier excretion via bile or urine (Jessen et 
al. 2003; Yang et al. 2017).  
1.14. Rationale 
Determining the possible transmembranes responsible for symporting the 
glucuronides in GusB could have a major effect in the medicine industry. By 
using other transporters (such as LacY and XylE) which share similar 
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structures with GusB and applying their findings, this could assist in narrowing 
down its molecular recognition sites. Once the GusB specific recognition of 
glucuronides is better understood, this protein transporter could have various 
uses. 
Firstly, this research could impact the current level of knowledge surrounding 
major facilitator superfamily members. By fusing different parts of transporters 
(some already known structurally i.e LacY and others not i.e GusB) together 
which share similar homology, this could provide information regarding their 
recognition sites, crystal structures and function. Furthermore, the theory and 
results from this project could be applied to other MFS members to try and 
understand them more in depth. 
Moreover, the research could contribute to the biosensor industry. By having 
the ability to specify GusB in order to narrow the range of glucuronides 
recognised, it can be engineering to detect ‘drug cheats’. Each drug produces 
a different type of glucuronide and the glucuronide transporter could be 
designed to recognise the glucuronides produced by the specific drugs that 
are being investigated.   
By genetically engineering GusB in order to recognise certain glucuronides, 
this could be used in future disease or disorder detection. Certain glucuronide 
levels could be monitored based on the amount of transportation carried out by 
these biosensors. For example, kernicterus is a neurological damage caused 
to the brain when bilirubin is not detoxified and mostly affects newborns 
(Shapiro et al. 2006; Ahlfors 2010). Therefore by designing the biosensor to 
recognise bilirubin mono and di-glucuronides which are formed when bilirubin 
is conjugated with glucuronic acid during detoxification, the levels of this 
product could be measured and therefore indicate whether levels produced are 
in the expected range or not.  
1.14.1. Aim 
The aim of this research is determine the functionality of the transmembranes 
in the glucuronide transporter, GusB by fusing it with lactose ‘permease’ 
(LacY), a well-known protein and locating GusB’s possible substrate binding 
sites. 
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1.14.2. Objectives 
The overall objectives for this research are: 
- To design primers for the fusion between gusB and lacY  
- To extract and purify plasmid DNA containing active gusB gene and 
genomic DNA containing the lacY gene 
- To successfully form a fusion of gusB and lacY and amplify it through 
PCR 
- To clone the transformants 
- To assess the functionality of the transformants using chromogenic 
glucuronides/ lactose 
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Chapter 2. MATERIALS AND METHODS 
2.1.  Chemicals, enzymes and commercial kits used 
Due to both genomic and plasmid DNA being used in this project, various kits 
were used to extract them. The DNeasy Blood and tissue kit (catalogue 
number 69504) was used to extract genomic DNA from JM109 whereas the 
QIAprep- Spin Miniprep Kit (catalogue number 27104) was used for plasmid 
pMJB33 and pTTQ18 extraction. Other kits used once PCR was completed 
were the QIAquick PCR Purification Kit (catalogue number 28104) in order to 
‘clean’ the PCR products and QIAquick DNA Gel Extraction Kit (catalogue 
number 28704). 
The enzymes required were: Taq Polymerase (catalogue number M780A) 
from Promega Ltd, DpnI (R0176S), restriction endonucleases EcoRI 
(catalogue number R0101S) and HindIII (catalogue number R0104S), T4 DNA 
ligase (catalogue number M0202S) from New England Biolabs. 
Due to the nature of the project, a variety of chemicals were required in order 
to conduct the research; they were as follows: 1kb ladder, GoTaq® G2 Flexi 
DNA Polymerase (catalogue number M7801) which contained 5x Flexi Buffer, 
Green Flexi Colourless Buffer and Magnesium Chloride solution from 
Promega Ltd; ampicillin 100 mg/ml  (catalogue number A5354), 5-bromo-4-
chloro-3indoyl glucuronide (catalogue number B5285), p-nitrophenyl-β-D-
glucuronide (catalogue number N1627) and isopropyl-thio-β-D-glucuronide 
(catalogue number 42897) from Sigma-Aldrich; Ethanol absolute (catalogue 
number E/0650/17), agarose powder (catalogue number BP1356-500), 
tryptone (catalogue number BP1421-500), yeast extract (catalogue number 
BP1422-500) and agar powder (catalogue number BP1423-500) which were 
from Fisher Scientific; SYBR® safe gel stain (catalogue number S33102) from 
Invitrogen and NEBuffer 2 (catalogue number B7002S) from New England 
Biolabs. 
2.2. Equipment used 
The main equipment needed was as follows: Nanodrop 2000 
Spectrophotometer, Peqstar thermocycler for PCR, Bio-Rad power pack for 
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electrophoresis, Heraeus Biofuge Pico table top microcentrifuge, centrifuge 
S430R, Bio-Rad ChemiDocTM MP Imaging System, JB Nova water bath and 
Shimadzu Spectrophotometer UV-1800.  
2.3. Preparation LB media and agar plates  
In order to grow the plasmid DNA (pMJB33 and pTTQ18) and genomic DNA 
(JM109), nutrient rich media’s were prepared according to the laboratory 
manual (Maniatis et al. 1982). As not many plates were required, the 
constituents for making 1 litre of media and agar was halved to make 500ml 
of each. Table 2-1 summarises the components for Luria-Bertani (LB) media 
and LB agar media in 500 millilitre. 
 
Table 2-1. The constituents for LB media and LB agar Media for 500 millilitres 
(Maniatis et al. 1982) 
LB Media  LB agar Media 
Components Weight Components Weight 
Bacto-Yeast Extract 
Bacto- tryptone 
Sodium Chloride 
2.5g 
5g 
5g 
 
Bacto- Yeast Extract 
Bacto- tryptone 
Sodium Chloride 
Agar 
2.5g 
5g 
5g 
7.5g 
 
Both the LB Media and agar media were mixed in glass bottles. Half of the 
bottles were filled with distilled water and all the ingredients were added and 
placed on a hot plate for a few minutes using a magnetic stirrer to mix them 
together and remove the lumps of powder. The bottles were then filled to the 
500 millilitre mark with distilled water and autoclaved.  
Once the bottles had cooled down, around 25 ml of LB agar media containing 
no ampicillin was poured in 4 plates and set aside to cool. For the remaining 
400ml of media, 400 microlitres (µl) of ampicillin was added to the agar media 
and mixed by inverting the bottle. As above, 25 ml of agar was then poured 
into the remaining plates and they were left to set before incubating them at 
37 oC to dry them off for a few hours. 
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2.4. Isolation of single colonies 
The dry agar plates were streaked using a loop. The loop was sterilised and 
then placed into the ‘deep’ strain (the ‘deep’ is from the frozen stock of the E. 
coli strains) containing plasmids MC1061 (pMJB33) and MC1061 (pTTQ18) 
and the genomic DNA JM109, see Table 2-2. Once placed in the deep, the 
loop was then streaked on the agar plates and were then left overnight in the 
incubator at 37 oC. Once the bacteria colonies had grown, single colonies 
from each plate were used for inoculation.  
 
E. coli  
Strains 
Description 
MC1061 
(pMJB33) 
E. coli expression vector which is ampicillin resistant and 
has an IPTG-inducible tac promoter 
 
MC1061 
(pTTQ18) 
 K-12 F– λ– Δ(ara-leu)7697 [araD139]B/r Δ(codB-
lacI)3 galK16 galE15 e14– mcrA0 relA1 rpsL150(StrR) spoT
1 mcrB1 hsdR2(r–m+) 
JM109 F´ traD36 proA+B+ lacIq Δ(lacZ)M15/ Δ(lac-proAB) glnV44 
e14- gyrA96 recA1 relA1 endA1 thi hsdR17 
 
2.4.1. Inoculation and growth of bacteria. 
For the inoculation, 10 ml of LB media along with 10 µl of ampicillin was 
pipetted into a sterilised flask. Using the loop, a single colony from the plates 
was collected and placed into media, waiting a few seconds to allow the 
transfer. Once the colony was transferred, the flask was placed into an orbital 
shaking incubator overnight @ 37oC to allow the bacteria to grow.  
2.5. Plasmid DNA Extraction 
The bacteria strains from the flasks which contained the pMJB33 and 
pTTQ18 plasmids respectively underwent mini prep in order to extract the 
Table 2-2. The various E. coli strains and their descriptions 
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plasmids using the the QIAprep Spin Miniprep Kit. In addition to this, the 
genomic DNA from the JM109 strains had to be extracted using the DNeasy 
Blood and tissue kit.  
2.6. PCR Primers 
2.6.1. PCR Primer Design 
For this project, primers had to be designed in order to fuse the first 6 
transmembranes helices of LacY with the last 6 transmembrane helices of 
GusB. In order to increase the success of this fusion, multiple primers were 
designed to improve the yield. The primer design followed a set of criteria 
(Reed et al. 2012 p.468) as well as being designed in the 5’ -3’ direction: 
 Length- 18-33 nucleotides base-long primers to increase the likelihood 
of the complementary strands to bind during amplification.  
 Base composition- the GC content had to be <50% due to GC bonds 
higher annealing temperate compared to AT. Polypurine and 
polypyrimidine tracts were avoided when designing the primers. 
 Melting temperature- the temperature at which both the forward and 
reverse primers can anneal with the template was calculated to not 
differ by 3 degrees in order to secure successful PCR reactions.  
2.6.2. Primer rehydration and dilution 
Upon delivery of the primers, they were lyophilised form and therefore needed 
rehydrating with T10E1 (10 mM Tris-HCl pH8.0 and 1 mM EDTA.Na2, pH8.0), 
see table 2-3 for the respective volumes added to each primer. However, 
after rehydration of the primers, the final concentrations (100 µM) were too 
high for PCR and therefore required further diluting to 10 µM. This was done 
by a 1 in 9 dilution; for every 1 µl of primer, 9 µl water was mixed. 
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Oligonucleotide 
Name 
Vol added 
(100pmol/µl) 
Final Concentration (µM) 
LacYF1 320 100 
LacYF2 299 100 
LacFY3 284 100 
gusBR1 318 100 
gusBR2 399 100 
lacYgusBF1Y 216 100 
LacYgusBF3Y 246 100 
lacYgusBR1Y 229 100 
lacYgusBR3Y 288 100 
 
2.7. PCR preparation 
Before carrying out the PCR reactions, the various components concentration 
had to be diluted to result in the correct concentration required for the PCR.  
2.7.1. Preparation of Deoxynucleotide Triphosphate (dNTP) 
One of the components for the PCR reaction is 1 mM of dNTP. This was 
made by diluting 10 µl of 10 mM dNTP with 90 µl of distilled water. 
2.8. PCR procedure 
For this project a two-step PCR was carried out; the first step PCR involved 
amplification of DNA composed of one flanking primer and one fusion primer 
with an overlapping region to create a fragment. During this process two 
fragments were produced to use in second step PCR.  Second step PCR then 
fused the two separate fragments from 1st step PCR together in order to 
create a fusion between the first 6 transmembers of lacY and the last 6 
transmembranes of gusB. Tables 2-4 and 2-5 shows the reagents required for 
first step and second step PCR respectively with the overall volume being 50 
µl.  
Table 2-3. Table showing the various primers and amount of 
T10E1 added for dilution 
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Component Volume (µl) Final Concentration  
Distilled H20 33.5 - 
5x Flexi Buffer 10 - 
1mM dNTP 1 20µM 
25mM MgCl2 2 1000 µM 
*10µM Forward Flanking 
Primer 
1 0.2 µM 
*10 µM Reverse Mutagenic 
Primer 
1 0.2µM 
DNA Template 1 42.7ng 
Taq polymerase 0.5 5u/µl 
Total 50 - 
*PCR reactions were also set up using the Forward fusion primers and Reverse 
flanking primers 
Before undergoing second step PCR, the PCR products from the first step 
PCR were loaded on a 1.5% agarose gel and underwent electrophoresis at 
70 V for 40 minutes. The gel was then assessed using the ChemiDoc MP 
Imaging system in order to show the separate DNA bands based on their 
molecular weight. All of the successful fragments were then purified using the 
Qaigen PCR Purification kit. After purification, every sample was treated 
Dpn1 by doing the following reaction; 5.5 µl cutsmart buffer and 1 µl of Dpn1 
was added to the PCR product tube before being incubated at 80 oC for 20 
minutes.  
Once all the successful samples were treated with Dpn1, the successful 
fragments were paired up with its respective pair and undergone second step 
PCR in order to obtain a fusion. The products were then analysed via an 
electrophoresis gel and molecular sizes were checked by comparing them to 
the 1 Kb ladder. 
 
 
 
Table 2-4. Components of first Step PCR equalling to 50 µl 
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Component Volume (µl) Final Concentration  
Distilled H20 32.5 - 
5x Flexi Buffer 10 - 
1 mM dNTP 1 20µM 
25 mM MgCl2 2 1000 µM 
10 µM Forward Flanking 
Primer 
1 0.2 µM 
10 µM Reverse Flanking 
Primer 
1 0.2µM 
*DNA Template 2 30-50ng 
Taq polymerase 0.5 5u/µl 
Total 50 - 
*1 µL of DNA template from each corresponding fragment in the relevant pair 
After second stage PCR, the products underwent agarose gel electrophoresis 
in order to check the success of the fusion. The gel was run at 70 V for 40 
minutes.  
During PCR, the repeating cycles include denaturation, annealing and 
polymerization of the DNA. Table 2-6 shows the settings chosen.  
 
Steps Temperature 
(oC) 
Time (minutes) Purpose 
1 95 5 Denaturation 
*2 94 1 Denaturation 
*3 63.5 ± 1.5 0.5 Annealing 
*4 72 2 Polymerization 
5 72 4 Completion of the 
extension 
6 8 60 Storage 
*Stages 2-4 is the cycle which was repeated 30 times. 
 
Table 2-5. Components of second Step PCR  
Table 2-6. The PCR settings used for this project- a gradient 
temperature was used 
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2.9. Gel extraction 
After running fusion PCR, the samples were loaded onto a gel and ran at 70 
V for 1 hour in order to separate the bands as much as possible. The fusion 
bands were then excised from the agarose gel using sharp scalpels. The gel 
slices were then weighed in microcentrifuge tubes (refer to the appendix- lab 
book for results) and the QIAquick Gel Extraction Kit protocol was followed to 
isolate the DNA fragments, remove the agarose and purify the DNA. This 
resulted in 50 µl of samples 
2.10. Restriction Digest 
In order to successfully ligate the PCR products, the DNA has to be cleaved 
with restriction enzymes EcoRI and HindIII to create sticky ends. In addition to 
this, the pTTQ18 vector had to be cleaved using the same restriction 
enzymes to prepare for insertion of the PCR product during ligation. The 
overall digestion time lasted 4 hours with both EcoRI and HindIII restriction 
enzymes being added at the start of the reaction and the reaction was 
incubated at 37 oC throughout. 
 
Components H183D (µl) pTTQ18 (µl) 
Distilled H20 37 37 
10 X Buffer 2 5 5 
BSA   10mg/ml 1 1 
Plasmid pTTQ18 - 5 
DNA fragments 5 - 
EcoRI µ/ml 1 1 
HindIII µ/ml 1 1 
 
2.11. Ligation 
Due to the digested pTTQ18 vector having phosphorylated areas, it had to be 
treated with Shrimp Alkaline Phosphatase (SAP) in order to remove them. 
This was done before ligation. The whole vector plasmid sample was treated 
Table 2-7.  Components for restriction double digest of the 
second step PCR product and Plasmid 
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with 1 µl SAP and 5 µl cut smart buffer and was incubated 37 degrees for 30 
minutes. 
For ligation, the total volume was no more than 20 µl for each reaction (see 
Table 2-8 for the components). The reaction mixtures were kept overnight at 
16oC before being used for transformation.   
 Volume (µl) 
Components L1 L2 L3 C1 C2 
Vector   (30-
50ng/µl) 
1 1 1 1 1 
Insert    (30-50ng/µl) 1 2 3 - - 
10x Ligase Buffer 2 2 2 2 2 
T4 Ligase 1 1 1 - 1 
H2O 15 14 13 17 16 
 
2.12. Making competent cells 
To make competent cells, Bacterial strain MC1061 was grown in no ampicillin 
LB media overnight at 37 oC in an orbital shaker (250rpm). 250 µl of the 
overnight MC1061 culture was then inoculated into fresh no ampicillin LB media 
and grown for 2 hours at 37 oC  with vigorous shaking (250rpm) to assist the 
bacteria to reach log phase (Light absorbance at A600 = 0.2-0.3). 
Immediately after reaching log phase, 1 ml of cells were harvested by 
centrifugation at 8000rpm and 4 oC for 2 minutes. The supernatant was 
discarded and the cells were resuspended in 0.5 ml of ice-cold sterile calcium 
solution (50 mM CaCl2, 10 mM Tris-HCl, pH 8.0). The suspension was placed 
in an ice bath for 15 minutes before being centrifugated again at 10,000 rpm 
for 1 minute at room temperature. The supernatant was discarded and the 
cells were resuspended in 66 µl ice-cold calcium solution. 
2.12.1. Transformation  
During the transformation, 10 µl of the ligated samples (L1, L2, L3, C1 and 
C2) were pipetted into 200 µl of the previously made competent cells and 
Table 2-8.  Components required for ligation of DNA fragment (H183D) 
and plasmid vector pTTQ18 
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were left to incubate for 30 minutes on ice. These samples were then heat 
shocked at 42 oC for 2 minutes in a water bath before being immediately 
placed in a slushy ice bath to chill for 2 minutes. 330 µl of LB media 
containing no ampicillin was pipetted into each sample before incubating the 
cells at 37 oC with vigorous shaking of 250 rpm for 60 minutes. After 
incubation, 200 µl of the incubated cells were plated onto ‘pre dried’ Lb agar 
plates containing ampicillin and spread with glass beads to ensure the cells 
dispersion. The plates containing the cells were then incubated overnight at 
37 oC before being examined the following day and photographed.  
2.13. Transformant confirmation 
Potential transformant colonies from the agar plates were inoculated 
overnight in LB media containing ampicillin. 1ml of cells was then harvested 
and extracted using the QIAprep Spin Miniprep Kit. Some of the extracted 
plasmid DNA underwent restriction digest using EcoRI or HindIII (refer to 
Section 2.9) in order to form a comparison between cut and uncut DNA on an 
agarose gel. If the plasmid was successfully cut, a linearized band of 
approximately 6 kb would be visible on the gel. 
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Chapter 3. RESULTS  
3.1. Open Reading Frame (ORF) analysis   
In order to design the primers, ORF’s for lacY and gusB had to be obtained. 
This was done by using online softwares and tools such as ExPASy translate 
tool (http://web.expasy.org/translate/) or NCBI (https://www.ncbi.nlm.nih.gov/). 
Another important feature of these tools is the start and stop codons are 
highlighted which assisted with identifying protein genomes within the 
sequences. 
3.2. Primer Design  
Primers were designed with some assistance from my supervisor. For this 
experiment, 11 primers were initially designed in order to increase the 
chances of getting a successful fusion; 3 forward flanking primers, 2 reverse 
flanking primers and 6 fusion primers. All of the primers were designed 
following the criteria mentioned in the methods chapter (Section 2.5.1). In 
addition to this, a third restriction enzyme recognition site (BamHI) was 
incorporated within the fusion primer linkers. Once all the primers were 
ordered, primers with the closest annealing temperatures were paired 
together to increase the potential of having successful fusions.  
 
Name Primer  Annealin
g temp 
Designer Synthesizer 
LacYF1 5’TAATGGAATTCGTATTTCGCG
TAAGGAAATCCA-3’ 
62.6oC CC*/WJL*  
 
Eurofin 
Genomics 
LacYF2 5’-
TAATGGAATTCCCCGTATTTCG
CGTAAGG-3’ 
61.8oC CC*/WJL*  
 
Eurofin 
Genomics 
LacYF3 5’TAATGGAATTCCCGTATTTCG
CGTAAGGAAATC-3’ 
64.5oC CC*/WJL*  
 
Eurofin 
Genomics 
*CC= Christine Ciocan   *WJL= Wei-Jun Liang 
 
Table 3-1. Forward primer designs for the LacY part of the fusion 
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Name Primer Reverse Complement      Annealin
g Temp 
Designer Synthesizer 
gusBR1 GCAATTAAT
CAGCGATA
TCACTAATT
AA 
5’-
TAATGAAGCTTTTAA
TTAGTGATATCGCT
GATTAATTGC -3’ 
64.1oC CC*/WJL*  
 
Eurofin 
Genomics 
gusBR2 CAATTAATC
AGCGATAT
CACTAATTA
A 
5’-
TAATGAAGCTTTTAA
TTAGTGATATCGCT
GATTAATTG -3’ 
62.1oC CC*/WJL*  
 
Eurofin 
Genomics 
*CC= Christine Ciocan   *WJL= Wei-Jun Liang 
 
Name Primer Annealing 
Temperature 
lacYgusB
F1 
 
5’-
TAATGGAATTCTAGGTGCCAACGGTGG
ATCCTGGTCCGTCATTG-3’ 
65.3 oC 
lacYgusB
F2 
5’-
TAATGGAATTCTAGGTGCCAACGGTGG
TGGATCCGGTAGTCCGTCATTGAAT-3’ 
66.8 oC 
lacYgusB
F3 
5’-
TAATGGAATTCGTGCCAACAGTGGTGG
ATCCGGTCCGTCATTGAATA-3’ 
63.9 oC 
 
lacYgusB
R1 
5’- 
TAATGAAGCTTCAATGACGGACCAGGA
TCCACCGTTGGCACCTA-3’    
65.3 oC 
lacYgusB
R2 
5’-
TAATGAAGCTTATTCAATGACGGACTAC
CGGATCCACCACCGTTGGCACCTA-3’ 
66.8 oC 
Table 3-2. Reverse primer designs for the GusB part of the fusion 
 
Table 3-3. Original forward and reverse (including the linker) primer designs   
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lacYgusB
R3 
5’-
TAATGAAGCTTTATTCAATGACGGACCG
GATCCACCACTGTTGGCAC-3’ 
63.9 oC 
 
 
 
 
 
 
 
3.3. Plasmid Extraction  
Before proceeding with PCR, the concentrations of plasmid DNA pMJB33 and 
pTTQ18 as well as the concentration of genomic DNA JM109 were measured 
with a DNA Nanodrop. It was important to keep the concentrations as close to 
50 ng/µl as possible. In addition to this, the OD260 (Optical Density at 260 
nm) reading was kept between 0.2-0.8 and the OD260/OD280 ratio was kept 
in between 1.8-2 as that is the acceptable ‘purity’ range. If any of these 
readings were too high, the DNA samples were diluted until the figures were 
in the necessary range. See Table 3-4 for the results from the Nanodrop. 
Plasmid Water (µl): 
DNA (µl) 
dilution 
ratio 
Concentration 
(ng/ µl)  
 
OD260 Reading 
(Concentration 
of nucleic acid 
in sample) 
OD260/OD
280 Ratio 
(Purity 
ratio)  
 
JM109 - 19.7 0.395 1.86 
pMJB33 - 157.3 3.074* 1.87 
pMJB33 8:1 39.9 0.797 1.81 
pTTQ18 - 17.6 0.352 1.84 
*Reading was too high and therefore diluted 
Table 3-4. Concentration, purity and dilution factors of genomic DNA JM109 
and plasmid pMJB33 and pTTQ18 
HindIII Restriction enzyme 
EcoRI Restriction enzyme 
gusB section 
lacY section 
Primer 
Linker with BamHI restriction site included 
Extra nucleotides 
Key 
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3.4. First round PCR- Amplification of DNA fragments Attempt 
1 
For the first round PCR, 5 fragments were amplified with 4 of the genes being 
successful amplified (samples 2, 3, 4 and 5). Bands 2 and band 5 were very 
faint but were visible to the human eye (refer to Appendix- lab book p.8 for 
pairings). A 1 kb ladder was loaded onto every gel in order to estimate 
weights for each band and compare the actual sizes with predicted sizes to 
confirm whether they are the desired fragments.  
 
 
Figure 3-1. Evaluation of first round PCR Products (#1, #2, #3, #4, #5) 
by agarose gel electrophoresis. The visualised bands on the gel are the 
correct predicted size of each fragment, thus suggesting successful 
amplification.  Lane 1: 1 kb ladder. Lane 2: No band visible. Lane 3: LacY 
fragment 2 (667 bp). Lane 4: LacY fragment 3 (661 bp). Lane 5: GusB 
fragment 1 (756 bp). Lane 6: GusB fragment 2 (755 bp).  
1.5% agarose gel was used and ran for 40 minutes at 70 V 
#1 #2 #3 #4 #5 
1000 bp 
750 bp 
500 bp 
1500 bp 
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3.5. DNA purification of successful samples from first round 
PCR 
The successful fragments (#2, #3, #4 and #5) from first stage PCR were 
purified in order to remove impurities from the previous reaction (refer to 
Appendix p.8 for pairings). This was carried out in attempt to improve the 
chances of getting a successful fusion. As illustrated, there is a bit of 
smearing still evident after purification, however it was decided to progress 
onto the next step due to time constraints.  
 
 
 
 
 
 
 
 
 
 
 
#2 #3 #4 #5 
1000 bp 
750 bp 
500 bp 
1500 bp 
Figure 3-2. Evaluation of DNA purification of the first round PCR Products 
(#2, #3, #4, #5) by agarose gel electrophoresis. The visualised bands on the 
gel are the purified samples from the first stage PCR. Lane 1: 1 kb ladder, Lane 
2: LacY fragment 2 (667 bp). Lane 3: LacY fragment 3 (661 bp). Lane 4: GusB 
fragment 1 (756 bp). Lane 5: GusB fragment 2 (755 bp). 
1.5% agarose gel was used and ran for 40 minutes at 70 V 
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3.6. Evidence of successful fusions formed using two step 
PCR 
As the project progressed, aims were being met such as forming a fusion 
between the two proteins by using two step PCR. As shown below, there 
were 4 successful fusions following four troubleshoots to improve the band 
quality and reduce smearing (see Appendix- lab book pages 13-17 for the 
gels from the other troubleshoots). Following the procedure, these bands 
were excised and extracted using the gel extraction kit and then underwent 
restriction digest. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3. Evaluation of the second stage PCR Products by agarose gel 
electrophoresis. After troubleshoot 4 consisting of reduced cycle numbers and 
reduced magnesium concentration, the smearing and unwanted band 
fragments have been reduced compared to the first troubleshoot (refer to 
Appendix- lab book 16). All four samples (circled above) were excised, 
extracted and purified. Lane 1: 1kb ladder. Lane 2: fusion formed between LacY 
fragment 2 and GusB 2. Lane 3: fusion formed between LacY fragment 3 and 
GusB 1. Lane 4: fusion formed between LacY fragment 2 and GusB 1. Lane 5: 
fusion formed between LacY fragment 3 and GusB 2.  
1.5% agarose gel was used and ran for 40 minutes at 70 V 
1500 bp 
1000 bp 
750 bp 
500 bp 
a• b• c• d• 
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3.7. Restriction Digest 1 of successful Fusion 
Samples a•, b• and d• from fusion (see Figure 3-3) underwent restriction 
double digest. Similar to the digestion of the plasmid, the samples were 
cleaved with EcoRI and HindIII following the protocol stated in methods 
(Section 2.9). It was decided to not digest sample c• as after gel extraction, 
the band was extremely faint (refer to Appendix- lab book p.19). As bands 
were faint after gel extraction (refer to Appendix- lab book p.19), each sample 
had two sets which underwent restriction digest which were later combined 
into one sample to increase DNA concentration. As evident on the gel, there 
is still 1.4 kb estimated band sizes visible after restriction digest which 
indicates that the digest appeared successful. However, due to the multiple 
bands being visible, the restriction digest was repeated with new DNA sample 
from the PCR fusions.  
 
 
 
 
 
 
 
 
1000 bp 
1500 bp 
750 bp 
a• a• b• b• d• d• 
Figure 3-4. Evaluation of the restriction digest of PCR samples. As evident 
on the agarose gel, the fusion bands for samples a•, b• and d• are still present 
after undergoing double digest. There is also other bands present which could 
indicate contamination. This prompted a repeat of digest with new samples. 
Lane 1: 1 kb ladder. Lane 2 and 3: Fusion 1 double digested with EcoRI and 
HindIII. Lane 4 and 5: Fusion 2 double digested with EcoRI and HindIII. Lane 5 
and 6: Fusion 3 double digested with EcoRI and HindIII.  
1.5% agarose gel was used and ran for 40 minutes at 70 V 
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3.8. Restriction Digest of plasmid  
The plasmid pTTQ18 underwent restriction double digest according to the 
protocol mentioned in Methods (Section 2.9) to linearize the plasmid vector 
and prepare it for ligation by cutting it twice. The enzymes used to cleave the 
plasmid were EcoRI and HindIII and as expected, a linearized 4.5 kb 
estimated size band was present on the gel after restriction digest, indicating 
successful cleaving of the vector.  
 
Figure 3-5. Evaluation of the restriction digest of plasmid pTTQ18. A 
linearized band location in between 4000 bp and 5000 bp indicates a successful 
digest of the plasmid. As it was a double digest, the smaller fragment which was 
cut from the fragment was not visible on the gel due to it being smaller than 250 
bp in size. Lane 1: 1 kb ladder. Lane 2 and 3: pTTQ18 plasmid double digested 
with EcoRI and HindIII (4.5 kb).  
1.5% agarose gel was used and ran for 40 minutes at 70 V 
1000 bp 
3000 bp 
5000 bp 
4000 bp 
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3.9. Restriction Digest repeat of PCR fusions 
Despite the previous restriction digest of the PCR fusions being successful, 
the double digest was repeated with new samples and fresh enzymes to 
reduce the amount of unwanted bands and contamination. The enzymes 
used were EcoRI and HindIII. As evident below, the sample bands were no 
longer visible on the gel. However nanodrop confirmed that DNA was still 
present (see Appendix- lab book p.21). This prompted investigation as the 
fusion was no longer visible after digest when it was expected to have 1.4 kb 
bands present. 
 
 
 
a• b• d• 
1000 bp 
1500 bp 
750 bp 
Figure 3-6. Evaluation of the restriction digest repeat of PCR samples. The 
restriction digest was repeated in attempt to reduce the amount of bands visible 
on the gel. However, no bands are visible on the gel despite the expectation of 
1.4 kb bands being present. This prompted investigation to identify the cause. 
Lane 1: 1 kb ladder. Lane 2, 3 and 4: no band evident after double digest with 
EcoRI and HindIII. 
1.5% agarose gel was used and ran for 40 minutes at 70 V 
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3.10. Restriction Digest repeat of PCR fusions 
After further investigation into the cause of the digest bands no longer being 
present on the gel, it became evident that there was an error in the initial 
primer designs (see 3.2.). By error, there were more than 2 restriction sites on 
the fragment which resulted in the fragment being cleaved into more than two 
fragments. These primers were then corrected and redesigned along with the 
assistance of Dr WJ Liang- creating 4 new fusion primers. 
 
Name Primer Annealing 
Temperature 
Designer Synthesizer 
lacYgusB
F1Y 
 
5’-
TAGGTGCCAACGGTGG
ATCCGTTCCGTCATTG-
3’ 
65.3 oC CC*/WJL
*  
 
Eurofin 
Genomics 
lacYgusB
F3Y 
5’-
TAGGTGCCAACAGTGGT
GGATCCGTTCCGTCATT
GAATA-3’ 
63.9 oC CC*/WJL
*  
 
Eurofin 
Genomics 
lacYgusB
R1Y 
5’- 
CAATGACGGAACGGAT
CCACCGTTGGCACCTA-
3’    
65.3 oC CC*/WJL
*  
 
Eurofin 
Genomics 
lacYgusB
R3Y 
5’-
TATTCAATGACGGAACG
GATCCACCACTGTTGGC
ACCTA-3’ 
63.9 oC CC*/WJL
*  
 
Eurofin 
Genomics 
*CC= Christine Ciocan   *WJL= Wei-Jun Liang 
 
 
Table 3-5. Corrected forward and reverse (including the linker) primer designs   
 
gusB section 
lacY section 
Linker with BamHI restriction site included 
Key 
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3.11. First round PCR- Amplification of DNA fragments 
(Attempt 2) 
Since redesigning the primers, the first step PCR was repeated to correct the 
design error. The previous fusion formed (see 3.6) was used as the template 
(refer to Appendix- lab book p.31 for pairings). During the first step PCR, 4 
fragments were amplified and they were all successful as illustrated on the 
gel. This particular troubleshoot consisted of reducing the magnesium 
concentration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-7. Evaluation of first round PCR repeat Products by agarose gel 
electrophoresis. The visualised bands on the gel are the correct predicted size 
of each fragment, thus suggesting successful amplification. Lane 1: 1 kb ladder, 
Lane 2: LacY fragment 1 (659 bp). Lane 3: LacY fragment 2 (666 bp). Lane 4: 
GusB fragment 1 (755 bp). Lane 5: GusB fragment 2 (758 bp). 
1.5% agarose gel was used and ran for 40 minutes at 70 V 
1000 bp 
500 bp 
750 bp 
1• 2• 4• 3• 
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3.12. DNA purification of successful 1st step PCR samples 
(Attempt 2) 
The chosen successful fragments from first stage PCR were purified to 
ensure the samples are cleaner and impurities were removed. As seen below, 
there was some slight smearing and unwanted bands still visible. However 
due to time constraint it was decided to continue with the project. Samples 5 
and d• are from two other troubleshoots that were carried out (refer to 
Appendix- lab book pages 28, 29 and 32). 
 
Figure 3-8. Evaluation of DNA purification of the first round PCR Products 
by agarose gel electrophoresis. The visualised bands on the gel are the 
purified samples from the first stage PCR. Lane 1: 1 kb ladder, Lane 2: LacY 
fragment 1 purified (659 bp). Lane 3: LacY fragment 2 purified (666 bp). Lane 4: 
GusB fragment 1 purified (755 bp). Lane 5: GusB fragment 2 purified (758 bp). 
1.5% agarose gel was used and ran for 40 minutes at 70 V 
1000 bp 
750 bp 
500 bp 
3• d• 2• 5 
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3.13. Evidence of successful fusions formed using two step 
PCR (Attempt 2) 
The second stage comprised of first step PCR products being paired up 
together (refer to Appendix- lab book p.35 for pairings) and being amplified to 
produce the fusion. The expected fusion band should be around 1.4 kb in 
size. There were multiple troubleshoots done to ensure a successful fusion. 
The image below is the result of the third troubleshoot (see appendix- lab 
book p.33 and p.34 for the other troubleshoots) where a gradient temperature 
PCR was run. As evident on the gel, there are faint fusion bands of the 
correct estimated size as well as a lot of smearing and unwanted bands 
present.  
Figure 3-9. Evaluation of the second stage PCR repeat products. After 3 
troubleshoots, there is still a lot of smearing and unwanted bands visible. Lane 
1: 1kb ladder. Lane 2 potential fusion formed between LacY fragment 1 and 
GusB 1 at 58 degrees. Lane 3. No potential fusion band. Lane 4: No potential 
fusion band. Lane 5:  potential fusion formed between LacY fragment 2 and 
GusB 2 at 60 degrees. Lane 6: No potential fusion band. Lane 7: potential 
fusion formed between LacY fragment 2 and GusB 2 at 62 degrees 
 1.5% agarose gel was used and ran for 40 minutes at 70 V 
1500 bp 
750 bp 
1000 bp 
X• Y• Y•• X•• X Y 
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3.14. First round PCR- Amplification of DNA fragments 
(Attempt 3) 
It was decided to attempt first step PCR again for a final time and without 
using the previous fusion as the DNA template (refer to Appendix- lab book 
p.36 for pairings). In addition to this, this repeat was focused on reducing the 
smearing as much as possibly to ensure a successful fusion. This was done 
by altering the magnesium concentration between the samples (see 
Appendix- lab book p.36 for constituents). As seen below (Figure 3-10), only 
2 out of 8 samples had the correct band sizes. The two bands visible are the 
lacY part required for the fusion, thus troubleshooting was required to ensure 
bands for the gusB half (Figure 3-11). The troubleshooting to obtain the gusB 
fragments consisted of altering the temperature. After all the troubleshooting 
attempts, the chosen fragments were then extracted and purified before 
continuing with the second step PCR. 
 
Figure 3-10. Evaluation of first round PCR repeat 3 products by agarose gel 
electrophoresis. Only two out of 8 samples had bands. Despite smearing still 
being evident, it had reduced as the magnesium concentration was decreased. 
Lane 1: 1 kb ladder. Lane 2: LacY fragment 1 (659 bp). Lane 3: LacY fragment 2 
(666 bp). Rest of the lanes: No bands evident. 
1.5% agarose gel was used and ran for 40 minutes at 70 V 
750 bp 
500 bp 
1000 bp 
1500 bp 
1∆ 2∆ 3∆ 4∆ 1- 2- 3- 4- 
    53 
 
 
 
 
Figure 3-11. Evaluation of first round PCR repeat 3 gusB fragments by 
agarose gel electrophoresis. Out of 6 samples, 3 bands were successfully 
produced with the correct fragment size of 755 bp. There is some smearing 
evident but the fragments were excised, extracted and purified. Lane 1: 1 kb 
ladder. Lane 2, 4 and 6: GusB fragment (755 bp). 
1.5% agarose gel was used and ran for 40 minutes at 70 V 
750 bp 
1000 bp 
500 bp 
1 2 3 4 5 6 
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3.15. Final second step PCR attempt (Attempt 3) 
Various variables were altered in attempt to form a fusion during attempt 3. 
Nonetheless, after three second step PCR troubleshoots (refer to Appendix- 
lab book p.44 for pairings), no fusion band appeared and therefore attempts 
were unsuccessful (refer to Appendix- lab book p. 41-45). Figure 3-12 is the 
result from the third troubleshooting where a gradient temperature was run, 
along with an increase in GoTaq polymerase concentration. Despite obtaining 
an unsuccessful fusion, unwanted bands have been reduced as the 
troubleshooting progressed. Due to time constraint, ligation, transformation 
and the functionality testing could not be completed. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
F1- F2- F3- F4- F5- F6- 
1500 bp 
1000 bp 
750 bp 
Figure 3-12. Evaluation of the second stage PCR Products by agarose gel 
electrophoresis. After 3 troubleshoots, there has been no fusion band of 1.4 kb 
in size present. Unwanted bands are no longer visible, however, the smearing is 
still evident throughout the troubleshoot attempts. Lane 1: 1 kb ladder. Lanes 2-
7: No fusion bands present. 
1.5% agarose gel was used and ran for 40 minutes at 70 V 
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Chapter 4. DISCUSSION 
The glucuronide transporter, a MFS family member, is a crucial transporter in 
ensuring E. coli survival in the mammalian intestines. GusB recognises a 
wide range of readily available glucuronides produced during the 
detoxification process of glucuronidation (Liang 1992; Liang et al 2005). This 
transporter then transports these across the bacterial membrane and into the 
cell where β-D-glucuronidase converts it into a carbon source (Wilson et al. 
1992; Roberts et al. 2002). Understanding the protein interactions between 
GusB and the other proteins in the gus operon, has led to a more thorough 
understanding of the mechanism and importance of their interaction.  
Moreover, understanding the mechanism and structure of one of the most 
well studied MFS proteins, LacY, has provided a fundamental part of this 
project. There has been in-depth studies on this transporter’s structure, 
specifically the N-domain being responsible for substrate binding and the C-
domain containing the proton translocation sites (Frillingos et al. 1998; 
Abramson et al. 2003; Guan and Kaback 2006; Guan et al. 2007). As GusB 
and LacY are members of the MFS, known information can be applied to and 
compared between the two as they have similar structures i.e 12 
transmembranes and cytoplasmic loop (Reddy et al. 2012). By using this 
knowledge and applying it to GusB, it may assist future deciphering of its 
molecular recognition sites.  
4.1. Results 
There has been some success in terms of achieving the objectives started in 
chapter 1. At the start of the project, progress was being made in terms of 
forming a fusion between the transmembranes of lacY and gusB using the 
PCR fusion method. As seen on Figures 3-1, 3-2 and 3-3, this was easily 
achieved with good results throughout as shown by DNA electrophoresis. 
However, the DNA bands were not as clean as hoped for and this was 
evident by the smearing. This could be an indication of possible 
contamination caused by equipment not being completely sterile or due to 
solutions and kits being shared by multiple students. However, after spending 
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a few weeks on running various troubleshoots in attempt to clean the bands, it 
was decided to persevere with the project.  
The successful fusion formed between the lacY and gusB genes underwent 
double restriction digest to prepare the fragment for ligation. Initially, the 
double digest appeared to be successful as bands at approximately 1.4 kb in 
size was still visible on the agarose gel. However, smearing and unwanted 
bands were evident (see Figure 3-4), thus the digest was repeated to try and 
result in cleaner bands on the electrophoresis gel as it could impact the 
success of the ligation and transformation later in the project.  
The double digest was repeated as shown on Figure 3-6. However, the 
fragment was no longer visible on the agarose gel after digest, especially as a 
1.4 kb band was expected to be visible. Initially it was thought the restriction 
enzymes may have been the issue, however, this was quickly eliminated 
during the digest of the plasmid as the correct band size of approximately 4.5 
kb was visible on the agarose gel.  
To attempt to isolate the cause, additional restriction digests troubleshoots 
were carried out. The next restriction digest troubleshoot involved increasing 
the amount of DNA sample in the digest sample as it was thought the dilution 
factor from the gel extraction may have been an issue. The one band visible 
after gel extraction was quite faint and around 5 ng/µl. Initially 5 µl of DNA 
sample was added to a total volume of 50 µl. This resulted in a dilution factor 
of 10, thus reducing the DNA concentration and therefore the band may not 
be visible on the gel. In order to overcome this issue, more DNA volume was 
added to the reaction, however there was still no band evident on the gel 
which prompted further investigation.  
This led to further investigation into the possible cause of the band no longer 
being present on the gel. After consulting with Dr Wei-Jun Liang, it became 
evident that there was an error with the primer design. The first set of fusion 
primers (refer to results) had more restriction sites designed within the 
sequence than it should have; overall there should have been 1 EcoRI 
restriction site and 1 HindIII site, however, there was in fact 3 restriction sites 
for each enzyme as restriction sites were added onto the end of the fusion 
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primers by human error. This issue resulted in the fusion fragment being cut 
into multiple small fragments, hence the fusion band no longer being visible 
on the gel. As this was a vital error, the fusion primers had to be redesigned 
to fix this mistake (refer to Results) by deleting the restriction sites on the end 
of each fusion primer and the project was repeated from first step PCR with 
the new primers. 
The whole PCR procedure was repeated from the beginning. First step PCR 
was repeated with the corrected primers. For the DNA template in this PCR, 
the previous fusion formed (Figure 3-3) was used to improve the chances of a 
successful fusion. Numerous troubleshoots were required to achieve the 
correct estimated sized bands (see Appendix- lab book p.29-32). The correct 
bands were then paired up (refer to Appendix for the pairings) and underwent 
fusion PCR. Unfortunately, this proved to require various troubleshoots as the 
fusion bands were difficult to achieve. Based on previous troubleshoots 
findings, the MgCl2 was the first factor to be altered.  MgCl2 is a cofactor for 
the Taq polymerase (GoTaq polymerase) and can affect its specificity and 
fidelity (Eckert and Kunkel 1991). Taq polymerase is a thermostable enzyme 
isolated from Thermus aquaticus and is responsible for DNA replication 
(Chien et al. 1976; Tindall and Kunkel 1988). However, for Go Taq 
polymerase to function, it requires a cofactor, in this case magnesium to 
assist in binding the dNTP to the DNA sequence (Lorenz 2012). Determining 
the optimal volume of MgCl2 in the reaction is crucial as it can decrease the 
specificity of the enzyme and therefore reduce its efficiency, possibly resulting 
in incorrect fragments being replicated. Troubleshoots containing 1 mM and 
0.5 mM MgCl2 were carried out, however there appeared to be no significant 
differences between the bands (refer to Appendix- lab book p.33 and p.41-
44).  
Following this troubleshoot, multiple PCR gradients runs were done to find the 
optimal temperature to produce the fusion. Firstly, the PCR were carried out 
at the calculated average annealing temperature. However, this proved 
unsuccessful as very faint or no fusion bands were present, only smearing 
was evident. A gradient PCR was then performed on numerous occasions, 
ranging from 64-58 degrees. In addition to this, it was thought that the 
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extension time may have been too generic at first as each enzyme has its 
own extension rate. Taq polymerase replication rate is approximately 1 kb per 
minute (personal communication with Dr WJ Liang, September 2017) 
therefore the extension time was changed according to the size of the 
fragment, this case approximately 1.4 kb in size and therefore the PCR 
extension time was set to 1.5 minutes. This change made no significant 
difference to obtaining a fusion. As this continued to prove unsuccessful and it 
was decided to restart the whole PCR procedure again. 
The PCR procedure was repeated again, starting with first step PCR. The 
DNA samples used were the original JM109 and pMJB33 samples instead of 
the previous fusion (see Figure 3-3 in Results). Similar conditions were used 
for this procedure based on the previous results and this was unsuccessful. In 
fact, the first step PCR had 4 troubleshoots and the most successful bands 
were chosen for the fusion PCR. However, to increase the chance of 
successful fusions, the chosen samples were purified followed by being gel 
extracted to clean the samples as much as possible. Once the corrected 
bands were achieved (see Results 3.14 and Appendix-lab book p. 36-39), 
fusion PCR was attempted once again.  
The fusion PCR proved difficult again with further troubleshoots being carried 
out. Fusion bands were not visible on the agarose gels, despite Nano drop 
confirming DNA being present (see Appendix- lab book p.45). Altered factors 
included; temperatures ranging from 64-54 degrees and different magnesium 
chloride concentrations as before. Another factor which underwent 
troubleshooting was the amount of DNA sample pipetted into the reaction. As 
seen on Figures 3-10 and 3-11 in the results chapter, the gusB fragments 
were brighter than the lacY fragments, this suggesting more DNA was 
present. Due to this, it was decided to do a 2:1 ratio of DNA sample into the 
PCR mix in attempt to gain a fusion. In addition to this, to encourage the 
GoTaq enzyme to replicate and fuse the fragments, its concentration was 
increased by adding 1 µl instead of the usual 0.5 µl. As seen on Figure 3-12 
in the results chapter, this still seemed to make no difference to obtaining a 
fusion. However, the amount of unwanted bands has reduced throughout the 
PCR troubleshooting. Unfortunately, due to time constraint the 
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troubleshooting had to be stopped. Nonetheless, understanding the theory of 
PCR and troubleshooting procedures have improved throughout the project 
and have been vital in understanding how to improve for future research.  
4.2. Challenges faced 
4.2.1. Primer design error 
For designing the primers used in this project, a protocol was followed (refer 
to Method) to result in successful bands being present on the agarose gel. 
Initially this was a difficult task due to the high content of cytosine and 
guanine residues in the lacY and gusB genome. This in turn added a bit of 
complication as the primers were designed to be within 1 degree of each 
other in attempt to increase the chances of successful annealing during PCR. 
However, due to the different amount of guanine and cytosine bases in each 
primer, it led to annealing temperatures being within 2 degrees of each other.  
One of the major challenges throughout this project was the struggle to obtain 
the fusion formed of lacY and gusB after correcting the primer design error 
(see Section 3.2. in Results). As there were numerous factors which could 
have influenced the success of the PCR, there were many troubleshoots 
involving altering these factors. However, it became evident that altering one 
factor made no significant difference to the lack of fusion and it may have 
been due to a combination of factors. It proved difficult as various factor 
combinations were tested, however it could be refined in future work. 
4.2.2. Unwanted bands and smearing 
Another challenge was having multiple unwanted extra bands within samples. 
Samples were treated with DpnI which targets the methylated areas on the 
DNA (Lacks and Greenberg 1975). They were also purified with the Qiagen 
PCR Purification kits. However, very faint extra bands were still visible on the 
gel. Consequently, this could have led to non-specific binding during PCR and 
result in an increase of extra bands. Moreover, smearing has been evident 
throughout the PCR results. Despite steps were taken to reduce this 
contamination, it remained unclear what was the exact cause of this. 
Therefore, samples underwent gel extraction after PCR purification in attempt 
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to reduce these two issues and get rid of unwanted DNA/ possible 
contaminants. 
4.2.3. Taq polymerase 
By running gradient PCR, the aim was to find the optimum temperature for 
GoTaq polymerase to fuse the two 1st step PCR fragments and replicate the 
fragment. As the gradient ranged from 64- 54 degrees, this could have 
impacted Taq polymerase’s fidelity as lowering the temperature can 
encourage non-specific binding. Furthermore, GoTaq polymerase does not 
have proof reading ability, thus if an error was made in the sequence, it would 
still be amplified (Huang et al. 1992; Kunkel 1992; Cline et al. 1996). This may 
have resulted in the extra bands evident on the agarose gels.  
4.2.4. Nanodrop 
The nanodrop spectrophotometers was helpful for giving an indication on 
DNA concentration and purity. However, it may have not always been 
accurate with its readings. The A260/280 ratio gives an indication of the purity 
of the sample with ‘pure’ samples being around 1.8-2.0 (Teare et al. 1997; 
Desjardins and Conklin 2010). However, all proteins absorb a certain 
wavelength, thus when taking the PCR fusion attempt samples, it could have 
given an inaccurate reading due to additional proteins other than the fusion 
being present in the sample or due to contamination. Therefore the nanodrop 
readings was taken as estimations and used along with the estimation of DNA 
concentrations from the agarose gel bands. 
4.3. Future research  
Despite the aim of this project not being fulfilled, this project has provided 
useful information which would assist it progressing further and completing 
the aim in the future. The PCR troubleshoots carried out during this project 
have provided a good starting guideline for future work. In addition to this, the 
future work can focus on clearing up the DNA, reducing the extra bands and 
smearing and ensuring a fusion is formed with the first 6 transmembranes of 
lacY and the 6 transmembranes of gusB.  
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Furthermore, the functionality of potential transformants should be assessed 
using chromogenic substrates and spectrophotometric monitoring. The 
chromogenic substrates which would be used for this testing are 5-bromo-4-
chloro-3-indoyl glucuronide (X-Gluc) and p-nitrophenyl-β-D-glucuronide 
(pNPG). If transportation is present, β-D-glucuronidase would cleave these 
glucuronides, resulting in a particular colour change; cleaved X-Gluc and 
pNPG resulting in a blue coloured aglycone sediment and yellow coloured 
soluble p-nitrophenol (pNP) respectively. The pNP colouring isn’t as evident 
to the naked eye as the X-Gluc, thus the absorbance intensity should be 
measured using a spectrophotometer at 405nm wavelength. These readings 
directly correlated to the concentration of pNP. 
Another aspect on improving future work may be using a thermostable 
enzyme with polymerase function which has 3’-5’ proof reading abilities and 
higher fidelity than Taq polymerase. One potential enzyme may be the Pfu 
polymerase (Cline et al. 1996; McInerney et al. 2014). This could assist in 
reducing non-specific binding and mutational fragments and therefore 
increasing the chances of the correct fragment being replicated. 
Future PCR runs should also be focussed on forming a fusion with the 
transmembranes swapped round i.e first 6 transmembranes of gusB and last 
6 transmembranes of lacY. Furthermore, these fusions should be repeated 
but with XylE instead of LacY. LacY and XylE have substrate binding sites in 
different transmembranes (refer to Chapter 1), yet it is unknown in GusB. 
Therefore by fusing each half with GusB and testing its functionality using 
chromogenic glucuronides, this could narrow down the possible substrate 
binding sites by indicating which transmembranes they are located in. 
Moreover, as structures of XylE and LacY have been crystallised, future 
experiments could indicate which structure GusB is more similar to as its 3D 
structure is currently unknown and could assist with crystallising GusB’s 
structure.  
Additionally, future experiments should investigate the expression of N-
domain (first 6 transmembranes) and C-domain (last 6 transmembranes) 
separately as this could give an indication to the possible 3D structure of 
GusB. In addition to this, if the domains can be independently expressed, it 
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could indicate that the cytoplasmic loop is not functionally significant and 
investigations could be focused on the specific transmembranes, their 
function and topology.  
The biotechnology industry is a growing industry, especially in drug design 
and biosensors. Once the specific binding sites in the glucuronide transporter 
have been located, this could prove an important finding when designing 
biosensors. Genetically engineered GusB with specific binding sites could act 
as a biosensor to detect drug use/ drug cheating. Glucuronides are products 
formed during the detoxification pathway and one way of disposing them is 
via urine. Biosensors could be designed to detect glucuronides produced by 
the detoxification of certain drugs in the urine, even in low concentrations. 
Furthermore, this method may become more favourable as it is less invasive 
than blood testing or taking saliva samples.  
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Chapter 5. CONCLUSION 
This research project was designed in attempt to narrow down the possible 
transmembranes containing the substrate binding sites of the glucuronide 
transporter. Unfortunately, producing a fusion between the first 6 
transmembranes of LacY and the last 6 transmembranes of GusB proved 
unsuccessful and therefore the aim could not be answered. Nonetheless, 
there was some success in terms of completing the objectives (see Chapter 
1). Objectives 1 and 2, designing fusion primers and extracting DNA 
containing the gusB and lacY genes respectively were successfully 
completed. Objective 3, successfully forming a fusion between the gusB and 
lacY genes using the PCR method was partially successful. The fusion was 
formed before the primer error was corrected (see Results chapter). 
Unfortunately this proved difficult to achieve again after the correction. Further 
troubleshooting is required to obtain the fusion which could then be 
functionally tested and provide possible insight into the substrate binding site 
locations within GusB. As mentioned in the discussion, by understanding the 
importance of each 6 transmembrane bundle of GusB, it could bring scientists 
closer to determining the exact substrate binding sites locations and 
establishing the 3D structure of this protein which would impact the science 
industry.  
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Chapter 7. APPENDIX 
Gus Operon  
CTGGTCAGAAATATGGCGTTTGACCTGGGTGAAAAAAATATTCGGGTAA
ATGGCATTGCGCCGGGGGCAATATTAACCGATGCCCTGAAATCCGTTAT
TACACCAGAAATTGAACAAAAAATGTTACAGCACACGCCGATCAGACGT
CTGGGCCAACCGCAAGATATTGCTAACGCAGCGCTGTTCCTTTGCTCGC
CTGCTGCGAGCTGGGTAAGCGGACAAATTCTCACCGTCTCCGGTGGTG
GGGTACAGGAGCTCAATTAATACACTAACGGACCGGTAAACAACCGTGC
GTGTTGTTTACCGGGATAAACTCATCAACGTCTCTGCTAAATAACTGGCA
GCCAAATCACGGCTATTGGTTAACCAATTTCAGAGTGAAAAGTATACGAA
TAGAGTGTGCCTTCGCACTATTCAACAGCAATGATAGGCGCTCACCTGA
CAACGCGGTAAACTAGTTATTCACGCTAACTATAATGGTTTAATGATGGA
TAACATGCAGACTGAAGCACAACCGACACGGACCCGGATCCTCAATGCT
GCCAGAGAGATTTTTTCAGAAAATGGATTTCACAGTGCCTCGATGAAAGC
CATCTGTAAATCTTGCGCCATTAGTCCCGGGACGCTCTATCACCATTTCA
TCTCCAAAGAAGCCTTGATTCAGGCGATTATCTTACAGGACCAGGAGAG
GGCGCTGGCCCGTTTCCGGGAACCGATTGAAGGGATTCATTTCGTTGAC
TATATGGTCGAGTCCATTGTCTCTCTCACCCATGAAGCCTTTGGACAACG
GGCGCTGGTGGTTGAAATTATGGCGGAAGGGATGCGTAACCCACAGGT
CGCCGCCATGCTTAAAAATAAGCATATGACGATCACGGAATTTGTTGCC
CAGCGGATGCGTGATGCCCAGCAAAAAGGCGAGATAAGCCCAGACATC
AACACGGCAATGACTTCACGTTTACTGCTGGATCTGACCTACGGTGTAC
TGGCCGATATCGAAGCGGAAGACCTGGCGCGTGAAGCGTCGTTTGCTC
AGGGATTACGCGCGATGATTGGCGGTATCTTAACCGCATCCTGATTCTC
TCTCTTTTTCGGCGGGCTGGTGATAACTGTGCCCGCGTTTCATATCGTAA
TTTCTCTGTGCAAAAATTATCCTTCCCGGCTTCGGAGAATTCCCCCCAAA
ATATTCACTGTAGCCATATGTCATGAGAGTTTATCGTTCCCAATACGCTC
GAACGAACGTTCGGTTGCTTATTTTATGGCTTCTGTCAACGCTGTTTTAA
AGATTAATGCGATCTATATCACGCTGTGGGTATTGCAGTTTTTGGTTTTTT
GATCGCGGTGTCAGTTCTTTTTATTTCCATTTCTCTTCCATGGGTTTCTCA
CAGATAACTGTGTGCAACACAGAATTGGTTAACTAATCAGATTAAAGGTT
GACCAGTATTATTATCTTAATGAGGAGTCCCTTATGTTACGTCCTGTAGA
AACCCCAACCCGTGAAATCAAAAAACTCGACGGCCTGTGGGCATTCAGT
    77 
 
CTGGATCGCGAAAACTGTGGAATTGATCAGCGTTGGTGGGAAAGCGCG
TTACAAGAAAGCCGGGCAATTGCTGTGCCAGGCAGTTTTAACGATCAGT
TCGCCGATGCAGATATTCGTAATTATGCGGGCAACGTCTGGTATCAGCG
CGAAGTCTTTATACCGAAAGGTTGGGCAGGCCAGCGTATCGTGCTGCGT
TTCGATGCGGTCACTCATTACGGCAAAGTGTGGGTCAATAATCAGGAAG
TGATGGAGCATCAGGGCGGCTATACGCCATTTGAAGCCGATGTCACGC
CGTATGTTATTGCCGGGAAAAGTGTACGTATCACCGTTTGTGTGAACAAC
GAACTGAACTGGCAGACTATCCCGCCGGGAATGGTGATTACCGACGAAA
ACGGCAAGAAAAAGCAGTCTTACTTCCATGATTTCTTTAACTATGCCGGG
ATCCATCGCAGCGTAATGCTCTACACCACGCCGAACACCTGGGTGGAC
GATATCACCGTGGTGACGCATGTCGCGCAAGACTGTAACCACGCGTCTG
TTGACTGGCAGGTGGTGGCCAATGGTGATGTCAGCGTTGAACTGCGTG
ATGCGGATCAACAGGTGGTTGCAACTGGACAAGGCACTAGCGGGACTTT
GCAAGTGGTGAATCCGCACCTCTGGCAACCGGGTGAAGGTTATCTCTAT
GAACTGTGCGTCACAGCCAAAAGCCAGACAGAGTGTGATATCTACCCGC
TTCGCGTCGGCATCCGGTCAGTGGCAGTGAAGGGCGAACAGTTCCTGA
TTAACCACAAACCGTTCTACTTTACTGGCTTTGGTCGTCATGAAGATGCG
GACTTACGTGGCAAAGGATTCGATAACGTGCTGATGGTGCACGACCACG
CATTAATGGACTGGATTGGGGCCAACTCCTACCGTACCTCGCATTACCC
TTACGCTGAAGAGATGCTCGACTGGGCAGATGAACATGGCATCGTGGTG
ATTGATGAAACTGCTGCTGTCGGCTTTAACCTCTCTTTAGGCATTGGTTT
CGAAGCGGGCAACAAGCCGAAAGAACTGTACAGCGAAGAGGCAGTCAA
CGGGGAAACTCAGCAAGCGCACTTACAGGCGATTAAAGAGCTGATAGC
GCGTGACAAAAACCACCCAAGCGTGGTGATGTGGAGTATTGCCAACGAA
CCGGATACCCGTCCGCAAGTGCACGGGAATATTTCGCCACTGGCGGAA
GCAACGCGTAAACTCGACCCGACGCGTCCGATCACCTGCGTCAATGTAA
TGTTCTGCGACGCTCACACCGATACCATCAGCGATCTCTTTGATGTGCT
GTGCCTGAACCGTTATTACGGATGGTATGTCCAAAGCGGCGATTTGGAA
ACGGCAGAGAAGGTACTGGAAAAAGAACTTCTGGCCTGGCAGGAGAAA
CTGCATCAGCCGATTATCATCACCGAATACGGCGTGGATACGTTAGCCG
GGCTGCACTCAATGTACACCGACATGTGGAGTGAAGAGTATCAGTGTGC
ATGGCTGGATATGTATCACCGCGTCTTTGATCGCGTCAGCGCCGTCGTC
GGTGAACAGGTATGGAATTTCGCCGATTTTGCGACCTCGCAAGGCATAT
TGCGCGTTGGCGGTAACAAGAAAGGGATCTTCACTCGCGACCGCAAAC
    78 
 
CGAAGTCGGCGGCTTTTCTGCTGCAAAAACGCTGGACTGGCATGAACTT
CGGTGAAAAACCGCAGCAGGGAGGCAAACAATGAATCAACAACTCTCCT
GGCGCACCATCGTCGGCTACAGCCTCGGTGACGTCGCCAATAACTTCG
CCTTCGCAATGGGGGCGCTCTTCCTGTTGAGTTACTACACCGACGTCGC
TGGCGTCGGTGCCGCTGCGGCGGGCACCATGCTGTTACTGGTGCGGGT
ATTCGATGCCTTCGCCGACGTCTTTGCCGGACGAGTGGTGGACAGTGT
GAATACCCGCTGGGGAAAATTCCGCCCGTTTTTACTCTTCGGTACTGCG
CCGTTAATGATCTTCAGCGTGCTGGTATTCTGGGTGCCGACCGACTGGA
GCCATGGTAGCAAAGTGGTGTATGCATATTTGACCTACATGGGCCTCGG
GCTTTGCTACAGCCTGGTGAATATTCCTTATGGTTCACTTGCTACCGCGA
TGACCCAACAACCACAATCCCGCGCCCGTCTGGGCGCGGCTCGTGGGA
TTGCCGCTTCATTGACCTTTGTCTGCCTGGCATTTCTGATAGGACCGAG
CATTAAGAACTCCAGCCCGGAAGAGATGGTGTCGGTATACCATTTCTGG
ACAATTGTGCTGGCGATTGCCGGAATGGTGCTTTACTTCATCTGCTTCAA
ATCGACGCGTGAGAATGTGGTACGTATCGTTGCGCAGCCGTCATTGAAT
ATCAGTCTGCAAACCCTGAAACGGAATCGCCCGCTGTTTATGTTGTGCA
TCGGTGCGCTGTGTGTGCTGATTTCGACCTTTGCGGTCAGCGCCTCGTC
GTTGTTCTACGTGCGCTATGTGTTAAATGATACCGGGCTGTTCACTGTGC
TGGTACTGGTGCAAAACCTGGTTGGTACTGTGGCATCGGCACCGCTGGT
GCCGGGGATGGTCGCGAGGATCGGTAAAAAGAATACCTTCCTGATTGG
CGCTTTGCTGGGAACCTGCGGTTATCTGCTGTTCTTCTGGGTTTCCGTC
TGGTCACTGCCGGTGGCGTTGGTTGCGTTGGCCATCGCTTCAATTGGTC
AGGGCGTTACCATGACCGTGATGTGGGCGCTGGAAGCTGATACCGTAG
AATACGGTGAATACCTGACCGGCGTGCGAATTGAAGGGCTCACCTATTC
ACTATTCTCATTTACCCGTAAATGCGGTCAGGCAATCGGAGGTTCAATTC
CTGCCTTTATTTTGGGGTTAAGCGGATATATCGCCAATCAGGTGCAAAC
GCCGGAAGTTATTATGGGCATCCGCACATCAATTGCCTTAGTACCTTGC
GGATTTATGCTACTGGCATTCGTTATTATCTGGTTTTATCCGCTCACGGA
TAAAAAATTCAAAGAAATCGTGGTTGAAATTGATAATCGTAAAAAAGTGC
AGCAGCAATTAATCAGCGATATCACTAATTAATATTCAATAAAAATAATCA
GAACATCAAAGGTGCAACTATGAGAAAAATAGTGGCCATGGCCGTTATTT
GCCTGACGGCTGCCTCTGGCCTTACCTCTGCTTATGCGGCGCAACTGG
CTGACGATGAAGCGGGACTACGCATCAGACTGAAAAACGAATTGCGCAG
GGCGGATAAGCCCAGTGCTGGCGCGGGAAGAGATATTTACGCATGGGT
    79 
 
ACAGGGAGGATTGCTCGATTTCAATAGTGGTTATTATTCCAATATTATTG
GCGTTGAAGGCGGGGCGTATTATGTTTATAAATTAGGTGCTCGTGCTGA
TATGAGTACCCGGTGGTATCTTGATGGTGATAAAAGTTTTGCTTTGCCCG
GGGCAGTAAAAATAAAACCCAGTGAAAATAGCCTGCTTAAATTAGGTCG
CTTCGGGACGGATTATAGTTATGGTAGCTTACCTTATCGTATTCCGTTAA
TGGCTGGCAGTTCGCAACGTACATTACCGACAGTTTCTGAAGGAGCATT
AGGTTATTGGGCTTTAACACCAAATATTGATCTGTGGGGAATGTGGCGTT
CACGAGTATTTTTATGGACTGATTCAACAACCGGTATTCGTGATGAAGGG
GTGTATAACAGCCAGACGGGAAAATACGATAAACATCGCGCACGTTCTT
TTTTAGCCGCCAGTTGGCATGATGATACCAGTCGCTATTCTCTGGGGGC
ATCGGTACAGAAAGATGTTTCCAATCAGATACAAAGTATTCTCGAGAAAA
GCATACCGCTCGACCCGAATTATACGTTGAAAGGGGAGTTGCTCGGCTT
TTACGCGCAGCTCGAAGGTTTAAGTCGTAATACCAGCCAGCCCAATGAA
ACGGCGTTGGTTAGTGGACAATTGACCTGGAATGCGCCGTGGGGAAGT
GTATTTGGCAGTGGTGGTTATTTGCGCCATGCAATGAATGGTGCCGTGG
TGGATACCGACATTGGCTATCCCTTTTCATTAAGTCTTGATCGTAACCGT
GAAGGAATGCAGTCCTGGCAATTGGGCGTCAACTATCGTTTAACGCCGC
AATTTACGCTGACATTTGCACCGATTGTGACTCGCGGCTATGAATCCAGT
AAACGAGATGTGCGGATTGAAGGCACGGGTATCTTAGGTGGTATGAACT
ATCGGGTCAGCGAAGGGCCGTTACAAGGGATGAATTTCTTTCTTGCTGC
CGATAAAGGGCGGGAAAAGCGCGATGGCAGTACGCTGGGCGATCGCCT
GAATTACTGGGATGTGAAAATGAGTATTCAGTATGACTTTATGCTGAAGT
AAAAAATAACGCCGGAGAGAAAAATCTCCGGCGTTTCAGATTGTTGACA
AAGTGCCGTTTTTTATGCCGGATGCGGCTAAACGCCTTATCCAGCCTAC
AAAAACTCATAAATTCAAAGTGTTGCAGGAAAAGGTAGGCCTGATAAGC
GTAGCGCATCAGGCAATCTCTGGTTTGTTTTCAGATGAAAACGCCGGAG
TGAAAATTCTCCGGCGTTTTGGCCGTGAATTACTGCTGCGGAATTGCCG
GTACAGCCGGAACGTTAAGAGCTGGCATCGCAAACATGCCAACAAAATC
TTCTAACGACATTTTCTGCCCATTTAACGTTATCTGACCGTTAGCATATTG
CAGGCTGGTGGTGATGGTATTGTCCTGCAAGGTGGTCAGACGGAACAT
CTGCCCCATTGCTGATGCACCTTCAACTTGCTGTTTCGCCAGTTTTTTCG
CTTGATCTTCCTGATAACCTTCCTCGCTACCTGAGTCATAAACTCAGTTG
CCATATCCACCGGAATGGTCAGTTTCGCATCCAGAGATTTAACCGAACG
ATCTACTTCCTGCGCCAGCGTTTGCGGCGCTTCTTTAGTCGTTGCCGGA
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TCTTTCAGGAACAGCGACAGATTCAGGGCACTTTCACCCTGACTGTTTTT
CCAGCTTAGCGGCGCGATAGTAATCACCGGATCGCCTTTCAGCATCAGC
GGCAGGGCGCTAAAGAAGGCTTCCGTCACTTTCTCCTGATAAAGTTCGG
GGTTGTTGGCAATTTCTGGCTGTCGCGACAGCGCCTGAGTTTGCGCGTT
ATATTGCTGGCTAAACTGATGCCAGGCTTCACCATCAATCTGGCCGACTT
TTAAAGTCAGCTTGCCGCTGCCCAGATCCTGATTCTGTACCTTCAGGCT
GTTTAGCGAGTAATCCAGTTGGCTATTGATCGTTTTACCGTCATTGACCA
GATCCGATTTACCGCTGATCTCCATGCCTTCCAGCAGTGCCAGTTCTTTG
CCTTCCACTGAAATGGTCATTTTTTCCAGTGACAGTTTTTGATTTCCTACA
CGCTCACCAAAACTTGCCAGCGTGCTGGAACCGTCGGTTTTCAGATTAT
TAAAGGTCAACTGCACTTTCTGGTTGTATTCGTTAACTGCGTCTATCCGA
ACCACTTTGCGCCTCCCCGGAAAGGGAGATGGCTTTGCGTCTCTGTCAG
CATTTAACTGGAACTCGCCGCCGCTAAAGGCGACTTTTTCATCCTTTTGC
TCGTAATTCAGTGGCTTGAGCGAAATATCGGAACTGGAATCACCGCTGT
AACCAATGCGCGAGTTAATCTCAAAAGGCGTTTCACCTTTTGCCATATCA
AACAGTGGTTTGCTTACTTCGTTATTAACCAGCGTGGTTTGAATTGATGC
CATCGACGGGATCAGGTTCAGTTTTTTAAGCTGGGCAAGCGGGAAGGG
ACCATGATCAACCGATTCGTTGAAGATGACGCTCTGACCGCTTTTAATCC
ACGGATTTTCTTTCCCGGCAATGGGTTTCACCAACAGTTGCAACTGGCT
GCTGAATACGCCGCGATGATAGTTTTGATAACTCACTTCCAGGTTGGATT
CAGGAGCTGTCAGTTTGAGTTGCGCGTTCGCCTGCGCGACCATGTCTTC
GAGATGGGTTTCAATCTTCTTGCCTGTATACCATGCGCCGCCTGTCCAG
ACTACGCCTAGCGCAACAATGACGCCTACCGCTACCAGCGATTTATTCA
TAATGATTATCCATAAAATGAAATCAGGCGGACTGGCCGCCTGAAGGTG
TTATAAGCCTTTAATAAGCTT 
Lac Operon 
GACACCATCGAATGGCGCAAAACCTTTCGCGGTATGGCATGATAGCGCC
CGGAAGAGAGTCAATTCAGGGTGGTGAATGTGAAACCAGTAACGTTATA
CGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGTG
GTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAA
GCGGCGATGGCGGAGCTGAATTACATTCCCAACCGCGTGGCACAACAA
CTGGCGGGCAAACAGTCGTTGCTGATTGGCGTTGCCACCTCCAGTCTG
GCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCC
    81 
 
GATCAACTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGC
GTCGAAGCCTGTAAAGCGGCGGTGCACAATCTTCTCGCGCAACGCGTC
AGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCTG
TGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCTGAC
CAGACACCCATCAACAGTATTATTTTCTCCCATGAAGACGGTACGCGACT
GGGCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAAATCGCGCTGTT
AGCGGGCCCATTAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTG
GCATAAATATCTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAA
GGCGACTGGAGTGCCATGTCCGGTTTTCAACAAACCATGCAAATGCTGA
ATGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGC
GCTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGC
GGATATCTCGGTAGTGGGATACGACGATACCGAAGACAGCTCATGTTAT
ATCCCGCCGTCAACCACCATCAAACAGGATTTTCGCCTGCTGGGGCAAA
CCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTGAAGG
GCAATCAGCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGC
GCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATG
CAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAA
CGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACT
TTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTT
CACACAGGAAACAGCTATGACCATGATTACGGATTCACTGGCCGTCGTT
TTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCC
TTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCC
GCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGC
GCTTTGCCTGGTTTCCGGCACCAGAAGCGGTGCCGGAAAGCTGGCTGG
AGTGCGATCTTCCTGAGGCCGATACTGTCGTCGTCCCCTCAAACTGGCA
GATGCACGGTTACGATGCGCCCATCTACACCAACGTAACCTATCCCATT
ACGGTCAATCCGCCGTTTGTTCCCACGGAGAATCCGACGGGTTGTTACT
CGCTCACATTTAATGTTGATGAAAGCTGGCTACAGGAAGGCCAGACGCG
AATTATTTTTGATGGCGTTAACTCGGCGTTTCATCTGTGGTGCAACGGGC
GCTGGGTCGGTTACGGCCAGGACAGTCGTTTGCCGTCTGAATTTGACCT
GAGCGCATTTTTACGCGCCGGAGAAAACCGCCTCGCGGTGATGGTGCT
GCGTTGGAGTGACGGCAGTTATCTGGAAGATCAGGATATGTGGCGGAT
GAGCGGCATTTTCCGTGACGTCTCGTTGCTGCATAAACCGACTACACAA
ATCAGCGATTTCCATGTTGCCACTCGCTTTAATGATGATTTCAGCCGCGC
    82 
 
TGTACTGGAGGCTGAAGTTCAGATGTGCGGCGAGTTGCGTGACTACCTA
CGGGTAACAGTTTCTTTATGGCAGGGTGAAACGCAGGTCGCCAGCGGC
ACCGCGCCTTTCGGCGGTGAAATTATCGATGAGCGTGGTGGTTATGCCG
ATCGCGTCACACTACGTCTGAACGTCGAAAACCCGAAACTGTGGAGCGC
CGAAATCCCGAATCTCTATCGTGCGGTGGTTGAACTGCACACCGCCGAC
GGCACGCTGATTGAAGCAGAAGCCTGCGATGTCGGTTTCCGCGAGGTG
CGGATTGAAAATGGTCTGCTGCTGCTGAACGGCAAGCCGTTGCTGATTC
GAGGCGTTAACCGTCACGAGCATCATCCTCTGCATGGTCAGGTCATGGA
TGAGCAGACGATGGTGCAGGATATCCTGCTGATGAAGCAGAACAACTTT
AACGCCGTGCGCTGTTCGCATTATCCGAACCATCCGCTGTGGTACACGC
TGTGCGACCGCTACGGCCTGTATGTGGTGGATGAAGCCAATATTGAAAC
CCACGGCATGGTGCCAATGAATCGTCTGACCGATGATCCGCGCTGGCT
ACCGGCGATGAGCGAACGCGTAACGCGAATGGTGCAGCGCGATCGTAA
TCACCCGAGTGTGATCATCTGGTCGCTGGGGAATGAATCAGGCCACGG
CGCTAATCACGACGCGCTGTATCGCTGGATCAAATCTGTCGATCCTTCC
CGCCCGGTGCAGTATGAAGGCGGCGGAGCCGACACCACGGCCACCGA
TATTATTTGCCCGATGTACGCGCGCGTGGATGAAGACCAGCCCTTCCCG
GCTGTGCCGAAATGGTCCATCAAAAAATGGCTTTCGCTACCTGGAGAGA
CGCGCCCGCTGATCCTTTGCGAATACGCCCACGCGATGGGTAACAGTC
TTGGCGGTTTCGCTAAATACTGGCAGGCGTTTCGTCAGTATCCCCGTTT
ACAGGGCGGCTTCGTCTGGGACTGGGTGGATCAGTCGCTGATTAAATAT
GATGAAAACGGCAACCCGTGGTCGGCTTACGGCGGTGATTTTGGCGAT
ACGCCGAACGATCGCCAGTTCTGTATGAACGGTCTGGTCTTTGCCGACC
GCACGCCGCATCCAGCGCTGACGGAAGCAAAACACCAGCAGCAGTTTT
TCCAGTTCCGTTTATCCGGGCAAACCATCGAAGTGACCAGCGAATACCT
GTTCCGTCATAGCGATAACGAGCTCCTGCACTGGATGGTGGCGCTGGAT
GGTAAGCCGCTGGCAAGCGGTGAAGTGCCTCTGGATGTCGCTCCACAA
GGTAAACAGTTGATTGAACTGCCTGAACTACCGCAGCCGGAGAGCGCC
GGGCAACTCTGGCTCACAGTACGCGTAGTGCAACCGAACGCGACCGCA
TGGTCAGAAGCCGGGCACATCAGCGCCTGGCAGCAGTGGCGTCTGGC
GGAAAACCTCAGTGTGACGCTCCCCGCCGCGTCCCACGCCATCCCGCA
TCTGACCACCAGCGAAATGGATTTTTGCATCGAGCTGGGTAATAAGCGT
TGGCAATTTAACCGCCAGTCAGGCTTTCTTTCACAGATGTGGATTGGCG
ATAAAAAACAACTGCTGACGCCGCTGCGCGATCAGTTCACCCGTGCACC
    83 
 
GCTGGATAACGACATTGGCGTAAGTGAAGCGACCCGCATTGACCCTAAC
GCCTGGGTCGAACGCTGGAAGGCGGCGGGCCATTACCAGGCCGAAGC
AGCGTTGTTGCAGTGCACGGCAGATACACTTGCTGATGCGGTGCTGATT
ACGACCGCTCACGCGTGGCAGCATCAGGGGAAAACCTTATTTATCAGCC
GGAAAACCTACCGGATTGATGGTAGTGGTCAAATGGCGATTACCGTTGA
TGTTGAAGTGGCGAGCGATACACCGCATCCGGCGCGGATTGGCCTGAA
CTGCCAGCTGGCGCAGGTAGCAGAGCGGGTAAACTGGCTCGGATTAGG
GCCGCAAGAAAACTATCCCGACCGCCTTACTGCCGCCTGTTTTGACCGC
TGGGATCTGCCATTGTCAGACATGTATACCCCGTACGTCTTCCCGAGCG
AAAACGGTCTGCGCTGCGGGACGCGCGAATTGAATTATGGCCCACACC
AGTGGCGCGGCGACTTCCAGTTCAACATCAGCCGCTACAGTCAACAGCA
ACTGATGGAAACCAGCCATCGCCATCTGCTGCACGCGGAAGAAGGCAC
ATGGCTGAATATCGACGGTTTCCATATGGGGATTGGTGGCGACGACTCC
TGGAGCCCGTCAGTATCGGCGGAATTCCAGCTGAGCGCCGGTCGCTAC
CATTACCAGTTGGTCTGGTGTCAAAAATAATAATAACCGGGCAGGCCAT
GTCTGCCCGTATTTCGCGTAAGGAAATCCATTATGTACTATTTAAAAAAC
ACAAACTTTTGGATGTTCGGTTTATTCTTTTTCTTTTACTTTTTTATCATGG
GAGCCTACTTCCCGTTTTTCCCGATTTGGCTACATGACATCAACCATATC
AGCAAAAGTGATACGGGTATTATTTTTGCCGCTATTTCTCTGTTCTCGCT
ATTATTCCAACCGCTGTTTGGTCTGCTTTCTGACAAACTCGGGCTGCGCA
AATACCTGCTGTGGATTATTACCGGCATGTTAGTGATGTTTGCGCCGTTC
TTTATTTTTATCTTCGGGCCACTGTTACAATACAACATTTTAGTAGGATCG
ATTGTTGGTGGTATTTATCTAGGCTTTTGTTTTAACGCCGGTGCGCCAGC
AGTAGAGGCATTTATTGAGAAAGTCAGCCGTCGCAGTAATTTCGAATTTG
GTCGCGCGCGGATGTTTGGCTGTGTTGGCTGGGCGCTGTGTGCCTCGA
TTGTCGGCATCATGTTCACCATCAATAATCAGTTTGTTTTCTGGCTGGGC
TCTGGCTGTGCACTCATCCTCGCCGTTTTACTCTTTTTCGCCAAAACGGA
TGCGCCCTCTTCTGCCACGGTTGCCAATGCGGTAGGTGCCAACCATTCG
GCATTTAGCCTTAAGCTGGCACTGGAACTGTTCAGACAGCCAAAACTGT
GGTTTTTGTCACTGTATGTTATTGGCGTTTCCTGCACCTACGATGTTTTT
GACCAACAGTTTGCTAATTTCTTTACTTCGTTCTTTGCTACCGGTGAACA
GGGTACGCGGGTATTTGGCTACGTAACGACAATGGGCGAATTACTTAAC
GCCTCGATTATGTTCTTTGCGCCACTGATCATTAATCGCATCGGTGGGAA
AAACGCCCTGCTGCTGGCTGGCACTATTATGTCTGTACGTATTATTGGCT
    84 
 
CATCGTTCGCCACCTCAGCGCTGGAAGTGGTTATTCTGAAAACGCTGCA
TATGTTTGAAGTACCGTTCCTGCTGGTGGGCTGCTTTAAATATATTACCA
GCCAGTTTGAAGTGCGTTTTTCAGCGACGATTTATCTGGTCTGTTTCTGC
TTCTTTAAGCAACTGGCGATGATTTTTATGTCTGTACTGGCGGGCAATAT
GTATGAAAGCATCGGTTTCCAGGGCGCTTATCTGGTGCTGGGTCTGGTG
GCGCTGGGCTTCACCTTAATTTCCGTGTTCACGCTTAGCGGCCCCGGCC
CGCTTTCCCTGCTGCGTCGTCAGGTGAATGAAGTCGCTTAAGCAATCAA
TGTCGGATGCGGCGCGACGCTTATCCGACCAACATATCATAACGGAGTG
ATCGCATTGAACATGCCAATGACCGAAAGAATAAGAGCAGGCAAGCTAT
TTACCGATATGTGCGAAGGCTTACCGGAAAAAAGACTTCGTGGGAAAAC
GTTAATGTATGAGTTTAATCACTCGCATCCATCAGAAGTTGAAAAAAGAG
AAAGCCTGATTAAAGAAATGTTTGCCACGGTAGGGGAAAACGCCTGGGT
AGAACCGCCTGTCTATTTCTCTTACGGTTCCAACATCCATATAGGCCGCA
ATTTTTATGCAAATTTCAATTTAACCATTGTCGATGACTACACGGTAACAA
TCGGTGATAACGTACTGATTGCACCCAACGTTACTCTTTCCGTTACGGGA
CACCCTGTACACCATGAATTGAGAAAAAACGGCGAGATGTACTCTTTTCC
GATAACGATTGGCAATAACGTCTGGATCGGAAGTCATGTGGTTATTAATC
CAGGCGTCACCATCGGGGATAATTCTGTTATTGGCGCGGGTAGTATCGT
CACAAAAGACATTCCACCAAACGTCGTGGCGGCTGGCGTTCCTTGTCGG
GTTATTCGCGAAATAAACGACCGGGATAAGCACTATTATTTCAAAGATTA
TAAAGTTGAATCGTCAGTTTAAATTATAAAAATTGCCTGATACGCTGCGC
TTATCAGGCCTACAAGTTCAGCGATCTACATTAGCCGCATCCGGCATGA
ACAAAGCGCAGGAACAAGCGTCGCATCATGCCTCTTTGACCCACAGCTG
CGGAAAACGTACTGGTGCAAAACGCAGGGTTATGATCATCAGCCCAACG
ACGCACAGCGCATGAAATGCCCAGTCCATCAGGTAATTGCCGCTGATAC
TACGCAGCACGCCAGAAAACCACGGGGCAAGCCCGGCGATGATAAAAC
CGATTCCCTGCATAAACGCCACCAGCTTGCCAGCAATAGCCGGTTGCAC
AGAGTGATCGAGCGCCAGCAGCAAACAGAGCGGAAACGCGCCGCCCA
GACCTAACCCACACACCATCGCCCACAATACCGGCAATTGCATCGGCAG
CCAGATAAAGCCGCAGAACCCCACCAGTTGTAACACCAGCGCCAGCATT
AACAGTTTGCGCCGATCCTGATGGCGAGCCATAGCAGGCATCAGCAAA
GCTCCTGCGGCTTGCCCAAGCGTCATCAATGCCAGTAAGGAACCGCTGT
ACTGCGCGCTGGCACCAATCTCAATATAGAAAGCGGGTAACCAGGCAAT
CAGGCTGGCGTAACCGCCGTTAATCAGACCGAAGTAAACACCCAGCGT
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CCACGCGCGGGGAGTGAATACCACGCGAACCGGAGTGGTTGTTGTCTT
GTGGGAAGAGGCGACCTCGCGGGCGCTTTGCCACCACCAGGCAAAGA
GCGCAACAACGGCAGGCAGCGCCACCAGGCGAGTGTTTGATACCAGGT
TTCGCTATGTTGAACTAACCAGGGCGTTATGGCGGCACCAAGCCCACCG
CCGCCCATCAGAGCCGCGGACCACAGCCCCATCACCAGTGGCGTGCGC
TGCTGAAACCGCCGTTTAATCACCGAAGCATCACCGCCTGAATGATGCC
GATCCCCACCCCACCAAGCAGTGCGCTGCTAAGCAGCAGCGCACTTTG
CGGGTAAAGCTCACGCATCAATGCACCGACGGCAATCAGCAACAGACT
GATGGCGACACTGCGACGTTCGCTGACATGCTGATGAAGCCAGCTTCC
GGCCAGCGCCAGCCCGCCCATGGTAACCACCGGCAGAGCGGTCGAC 
 
Primer Design 
>gusB 
MGALFLLSYYTDVAGVGAAAAGTMLLLVRVFDAFADVFAGRVVDSVNTRW
GKFRPFLLFGTAPLMIFSVLVFWVPTDWSHGSKVVYAYLTYMGLGLCYSLV
NIPYGSLATAMTQQPQSRARLGAARGIAASLTFVCLAFLIGPSIKNSSPEEMV
SVYHFWTIVLAIAGMVLYFICFKSTRENVVRIVAQPSLNISLQTLKRNRPLFML
CIGALCVLISTFAVSASSLFYVRYVLNDTGLFTVLVLVQNLVGTVASAPLVPG
MVARIGKKNTFLIGALLGTCGYLLFFWVSVWSLPVALVALAIASIGQGVTMTV
MWALEADTVEYGEYLTGVRIEGLTYSLFSFTRKCGQAIGGSIPAFILGLSGYI
ANQVQTPEVIMGIRTSIALVPCGFMLLAFVIIWFYPLTDKKFKEIVVEIDNRKK
VQQQLISDITN 
 
>lacY 
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLF
SLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVG
GIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVGWALCASIVGIMF
TINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALE
LFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTT
MGELLNASIMFFAPLIINRIGGKNALLLAGTIMSVRIIGSSFATSALEVVILKTLH
    86 
 
MFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYES
IGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
 
Fusion of first 6 transmembranes of lacY with last 6 transmembranes of gusB 
MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLF
SLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVG
GIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVGWALCASIVGIMF
TINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANPSLNISLQTLK
RNRPLFMLCIGALCVLISTFAVSASSLFYVRYVLNDTGLFTVLVLVQNLVGTV
ASAPLVPGMVARIGKKNTFLIGALLGTCGYLLFFWVSVWSLPVALVALAIASI
GQGVTMTVMWALEADTVEYGEYLTGVRIEGLTYSLFSFTRKCGQAIGGSIP
AFILGLSGYIANQVQTPEVIMGIRTSIALVPCGFMLLAFVIIWFYPLTDKKFKEI
VVEIDNRKKVQQQLISDITN 
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GusB and LacY LALIGN 
 
Waterman-Eggert score: 85;  23.7 bits; E(1) <  0.013 
19.7% identity (51.3% similar) in 304 aa overlap (1-278:23-
298) 
 
                 10        20        30        40            
50     
gusB   MGALFLLS--YYTDVAGVGAAAAGTMLLLVRVFDAFADVFAGRVVDSVNTR----
WG--- 
       ::: : .   .  :.  .. . .: ..  . .:. . . . : . :... :    
:     
lacY   
MGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITG 
             30        40        50        60        70        
80   
 
                 60        70        80        90       100         
gusB   ---
KFRPFLLFGTAPLMIFSVLVFWVPTDWSHGSKVVYAYLTYMGLGLCYSLVNIPYGSL 
           : ::..:  .::. ...::         :: :   ::     :.:..       
.. 
lacY   MLVMFAPFFIFIFGPLLQYNILV---------GSIVGGIYL-----
GFCFNAGAPAVEAF 
             90       100                110            120         
 
      110          120       130       140       150       160      
gusB   ATAMTQQPQ---
SRARLGAARGIAASLTFVCLAFLIGPSIKNSSPEEMVSVYHFWT---I 
          .... .   .:::. .  : :   ..: . :    .:.:.        . ::      
lacY   IEKVSRRSNFEFGRARMFGCVGWALCASIVGIMF----TINNQ--------
FVFWLGSGC 
      130       140       150       160                   170       
 
            170       180       190           200         210       
gusB   VLAIAGMVLYFICFKSTRENVVRIVAQP----SLNISLQTLKRNRPLFM--
LCIGALCVL 
       .: .: ....      .  .:.  :.      ::...:. ... .  :.    
::. :.  
lacY   
ALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTY 
        180       190       200       210       220       230       
 
        220       230         240       250       260       
270     
gusB   ISTFAVSASSLFYVRYVLNDTG--
LFTVLVLVQNLVGTVASAPLVPGMVARIGKKNTFLI 
        ..:  . ...:   .. .. :  .:  .. . .:... .   ..: .. ::: 
::..:. 
lacY   -DVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNA-
SIMFFAPLIINRIGGKNALLL 
         240       250       260       270        280       
290     
 
    88 
 
            
gusB   GALL 
       .. . 
lacY   AGTI 
            
 
>-- 
 Waterman-Eggert score: 61;  18.6 bits; E(1) <  0.36 
22.1% identity (57.4% similar) in 68 aa overlap (227-285:86-
153) 
 
        230       240       250              260       270          
gusB   LFYVRYVLNDTGLFTVLVLVQNLVGTV-------
ASAPLVPGMVARIGKKNTFLIGA--L 
       .:   ...    :.   .:: ..:: .       :.:: : ... .......: 
.:   . 
lacY   
MFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARM 
          90       100       110       120       130       140      
 
       280      
gusB   LGTCGYLL 
       .:  :. : 
lacY   FGCVGWAL 
         150    
 
>-- 
 Waterman-Eggert score: 51;  16.5 bits; E(1) <  0.86 
26.7% identity (60.0% similar) in 75 aa overlap (194-264:316-
389) 
 
           200       210       220       230         240       
250  
gusB   ISLQTLKRNRPLFMLCIGALCVLISTFAVSASSLFYVRYV--
LNDTGLFTVLVLVQNLVG 
       . :.::.  .  :.: .: .  . : : :  :. .:.     ... ... . ::. 
:.   
lacY   VILKTLHMFEVPFLL-
VGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYE 
         320       330        340       350       360       
370     
 
               260     
gusB   TVA--SAPLVPGMVA 
       ...  .: :: :.:: 
lacY   SIGFQGAYLVLGLVA 
          380          
 
 
 
 
    89 
 
 
Tm for PCR reaction (GIBCO-BRL) 
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Tm = 81.5 + 41 x CG% - 675/mers 
Annealing Temperature = Tm – 5 degree C 
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Plasmid Digest 
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Risk Assessment 
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Initial Review 
Notes: The 1st Review is an important milestone in the programme of study, 
which must be completed by 6 months (FT) or 12 months (PT).  
The purpose is to enhance the original proposal, to demonstrate your 
understanding of the research project, to identify any H&S / ethical issues; and 
to establish the timescale for the research and agreed research plan and future 
activities.  Progress is discussed with and reviewed by the Supervisory Team 
and assessed by an Independent Academic. 
Continuation is dependent on successful completion of this stage. 
Text fields will expand as required. Use the TAB key to move to the next field. 
1. POSTGRADUATE RESEARCHER DETAILS 
Student 
number 
    4538459  
Full name       Christine Ciocan 
Mode of 
study 
 Full Time  Part Time 
Date of 
registration 
     23/01/2017 
2. INITIAL REVIEW: RESEARCH TO DATE 
Abstract (c. 500 words) 
     The major facilitator superfamily (MFS) is composed of various 
membrane transporters which can be located ubiquitously. Each 
transporter is involved in a crucial physiological process where it carries 
molecules across membranes by differing transport mechanisms. The 
transporters act as symporter, antiporter or uniporter in order to 
transport the molecules. In this research project, the focus will be on 
two secondary membrane transporters which share similar homologies 
but are involved in different processes. They are: Lactose permease 
LacY and the glucuronide transporter GusB. LacY is a well-known 
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secondary transport protein which facilitates the movement of lactose 
molecules across a membrane by utilising the movement of H+ ions 
down the concentration gradient. GusB on the other hand plays a role 
in acquiring glucuronides for enterobacteria Escherichia coli for their 
survival. Contrarily, the structure of GusB is not as fully understood. In 
this project, the first 6 membranes of LacY will be fused with the last 6 
transmembranes of GusB by undergoing fusion PCR. The functionality 
of this fusion would then be tested. If the results are successful and the 
fusion still transports molecules, it could suggest that; as previously 
predicted, the structures of GusB and LacY are similar. Therefore, this 
discovery (if successful), could bring scientists a step closer to 
understanding the glucuronide transporter and other MFS members.  
Title of thesis 
     Investigating the functionality of a fusion between two major 
facilitator superfamily members; LacY and GusB using a fusion 
Polymerase Chain Reaction. 
Background to the topic (This is the context to your research and 
should include reference to the academic literature c. 500 words) 
      The major facilitator superfamily (MFS) is one of the largest 
secondary carrier superfamilies in the natural world. It is compiled of 
various membrane transporter families that can be found in both 
prokaryotic and eukaryotic cells organisms. Examples of transporters 
which are members of the MFS include; glucose transporters (GLUT), 
lactose permease (LacY), xylose transporter (XylE), glucuronide 
transporter (GusB) and melibiose transporter (MelB).The members of 
the MFS can act as symporters, antiporters or uniporters in order to 
transport ions, substrates and other molecules across membranes 
(Reddy et al. 2012; Yan 2015; Quistgaard et al. 2016). Each transporter 
is involved in a different physiological process, yet structurally they can 
be quite similar. For this project two members of the MFS will be fused 
together and the functionality will be tested. The two MFS members 
    96 
 
focussed on in this project are lactose permease and the glucuronide 
transporter.  
Lactose permease is a well-studied transporter located in Escherichia 
coli (E.coli). It is a symporter that carries lactose across the 
phospholipid layer by utilising the movement of H+ ions down the 
concentration gradient. This transporter is composed of twelve 
transmembrane helices with N and C terminal domains (Abramson et 
al. 2003). Due to the fact that this protein has been well studied, 
scientists have been able to formulate a crystal structure (Stroud 2007) 
and reveal its conformation and binding sites when transporting 
lactose.  
On the other hand, GusB is not as well-known as LacY. E.coli which 
survive in the human gut have used this transporter in order to survive. 
GusB transports glucuronides, which are formed during 
glucuronidation, into the E.coli to use as a carbon source. Similarly to 
LacY, GusB has twelve transmembrane α-helices (Liang 1992; Ishii 
2013 p.199) with N and C domains. However the substrate recognition 
sites are not yet known for this protein. Therefore, by applying the 
existing knowledge from LacY, the aim of this study is to narrow down 
the possible recognition site locations. 
Abramson, J., Smirnova, I., Kasho, V., Verner, G., Kaback, H.R. and 
Iwata, S., 2003. Structure and mechanism of the lactose permease of 
Escherichia coli. Science [online], 301 (5633), 610-615.  
Ishii, N., 2013. Two-Dimensional Crystalline Array Formation of 
Glucuronide Transporter from Escherichia coli by the Use of 
Polystyrene Beads for Detergent Removal. The Journal of Membrane 
Biology [online], 246 (1), 199-207. 
Liang, W.J., 1992. The Glucuronide Transport System of Escherichia 
coli. Thesis (PhD). University of Cambridge.  
Quistgaard, E. M., Low, C., Guettou, F. and Nordlund, P., 2016. 
Understanding transport by the major facilitator superfamily (MFS): 
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structures pave the way. Nature Reviews: Molecular Cell Biology 
[online], 17 (2), 123-132.   
Reddy, V. S., Shlykov, M. A., Castillo, R., Sun, E. I. and Saier Jr, M. H., 
2012. The major facilitator superfamily (MFS) revisited. The FEBS 
journal [online], 279 (11), 2022-2035. 
Stroud, R. M., 2007. Transmembrane transporters: An open and closed 
case. Proceedings National Academy of Sciences of the United States 
of America [online], 104 (5), 1445-1446.  
Yan, N., 2015. Structural Biology of the Major Facilitator Superfamily 
Transporters. Annual Review of Biophysics [online], 44, 257-283.  
Research questions – the aims of the research (This should take the 
form of a short, achievable statement(s) informing the reader of the 
purpose of the study c. 500 words) 
     The aim of this research is to assess the functionality of a fusion 
formed between two members of the major facilitator superfamily 
(MFS) members; in this case the fusion composed of LacY and GusB. 
Objectives of the research (These must be measurable and 
achievable c. 500 words) 
     The overall objectives for this research are: 
- To design primers for the fusion between gusB and lacY  
- To extract and purify plasmid DNA containing active gusB and 
lacY genes 
- To successfully form a fusion of gusB and lacY and amplify it 
through PCR 
- To clone the transformants  
- To assess the functionality of the transformants using chromo-
genic glucuronides/ lactose 
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Outline of proposed methodology (Including data collection, analysis 
and sampling, c. 500 words) 
     This research will occur in a laboratory. It will consist of fusing 
two separate transporters genes (lacY and gusB) that belong to the 
same family. This will be carried out using two step PCR to fuse the 
first half (6 transmembranes) of LacY with the last 6 membranes of 
GusB. The first stage of PCR involves fusing the forward primer of lacY 
with the reverse primer of lacY/ gusB linker and the lacY/gusB linker 
forward with the gusB reverse respectively by using appropriate 
annealing temperatures. Once these fragments have been formed, the 
second stage of PCR will be carried out in an attempt to fuse the two 
separate fragments formed previously. Electrophoresis would be 
performed after every PCR in order to confirm base pair sizes of the 
fragments and to illustrate the DNA quality. This fused gene will then be 
ligated into a vector which had previously undergone restriction digest. 
Once the gene is successfully ligated, cloning will be the next part of 
the process in which functionality would be tested and the clone will be 
sent for sequencing. 
Please describe any ethical, health & safety or risk issues related 
to your proposed study (Outline what they are and how they will be 
addressed c. 250 words each) 
Ethical 
issues 
     N/A 
Health & 
safety 
issues 
     Using E.coli strains, using chemical reagents, 
using biological reagents 
Other risk 
Issues 
      
Proposed timescale for the work (Outline the plan for completing the 
work within the period of registr ation.  Identify all major milestones of 
the work and indicate how long each will take. c. 250 words) 
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     The milestones achieved so far are: 
- Decided on topic and project aim 
- Primers for the fusion have been designed 
- Lab work has started- Miniprep has been completed, DNA ex-
traction has been completed, the current stage of this project is 
using PCR in order to obtain a fusion. 
         For this project, the aim is to hand in the final piece of work in 
November. As it currently stands the project is achievable due to 
existing experience with the methodology, lab procedures and 
troubleshooting from previous undergraduate IRP research. The idea is 
to complete the practical work by August/ September time to allocate 
enough time for the write up. 
Agreed research plan and activities for the forthcoming months 
(Outline what you are planning to achieve in the forthcoming months, 
identify all major milestones of the work and indicate how long each will 
take c. 250 words) 
     In the next few months, the main focus will be to complete the 
practical work as well as focusing on completing the introduction for the 
thesis. The major milestones are: 
- Undergo stage 1 and stage 2 of PCR in order to fuse the two 
transporters (2-4 months) 
- Once the transporters are fused, performing a restriction digest 
and carry out ligation (1 month) 
- Start writing up the thesis- working on the introduction and 
method (2-4 months) 
- Continue reading papers 
How will your research contribute to new knowledge in this field? 
(c. 250 words) 
     This research could impact the current level of knowledge 
surrounding major facilitator superfamily members. By fusing different 
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parts of transporters (some already known structurally and others not) 
together which share similar homology, information could be applied to 
the less understood proteins such as GusB and other transporters in 
order to understand their functions and crystal structures. Furthermore, 
the theory and results from this project could be applied to other MFS 
members to decipher their structure.  
In addition to this, the research could contribute to the biosensor 
industry. Biological sensors could be engineered to detect ‘drug cheats’ 
or disorders by monitoring levels of molecules that are transported by 
certain sensors. For example, a biosensor which is designed with LacY 
or GLUT 2 could be used to detect glucose/galactose malabsorption as 
the functionality rate of the biosensor could indicate the molecule 
levels.  
3. COLLABORATIVE RESEARCH 
Do you intend conducting fieldwork or research using private 
archives or working in collaboration with others? 
 Yes    No   If relevant, a letter signifying appropriate permission will 
need to be appended. 
Collaborating Establishment A letter of 
support from the collaborating 
establishment confirming agreed 
arrangements must be attached.  If no 
collaboration has been arranged, a brief 
explanation should be given in all cases. 
      
Address of Collaborating 
Establishment 
      
Relationship between work to be 
undertaken in the collaborating 
establishment and at the University  
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